| | | | | ii | | | |
| | | | | iii | | | |
| | | | | v | | | |
| | | | | 1 | | | |
| | | | | 8 | | | |
| | | | | 10 | | | |
| | | | | 12 | | | |
| | | | | 39 | | | |
| | | | | 40 | | | |
| | | | | 41 | | | |
| | | | | 52 | | | |
| | | | | 64 | | | |
| | | | | 77 | | | |
| | | | | 81 | | | |
| | | | | 87 | | | |
| | | | | 90 | | | |
| | | | | 93 | | | |
| | | | | 99 | | | |
| | | | | 111 | | | |
| | | | | 115 | | | |
| | | | | 115 | | | |
| | | | | 116 | | | |
| | | | | F-1 | | |
| | |
Shares
Outstanding (millions) |
| |
Percentage(1)
|
| ||||||
EIC’s public stockholders (other than the PIPE Investors)
|
| | | | 23.9 | | | | | | 30.3% | | |
PIPE Investors (other than the Sponsor and its affiliates)
|
| | | | 10.5 | | | | | | 13.3% | | |
Sponsor (and its affiliates)
|
| | | | 8.9 | | | | | | 11.3% | | |
Current holders of Legacy Blade Stock and Legacy Blade Options(2)
|
| | | | 35.6 | | | | | | 45.1% | | |
Total EIC Class A common stock outstanding
|
| | | | 78.9 | | | | | | 100.0% | | |
| | |
Historical
Blade |
| |
Historical
EIC |
| |
Transaction
Accounting Adjustments |
| | | | | | | |
Pro Forma
Combined |
| ||||||||||||
| | |
(a)
|
| |
(b)
|
| | | | | | | | | | | | | | | | | | | ||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 7,511 | | | | | $ | 485 | | | | | $ | 240,725 | | | | | | (c) | | | | | $ | 344,729 | | |
| | | | | | | | | | | | | | | | | 125,000 | | | | | | (d) | | | | | | | | |
| | | | | | | | | | | | | | | | | (27,827) | | | | | | (e) | | | | | | | | |
| | | | | | | | | | | | | | | | | (1,165) | | | | | | (j) | | | | | | | | |
Restricted cash
|
| | | | 415 | | | | | | | | | | | | — | | | | | | | | | | | | 415 | | |
Prepaid expenses and other current assets
|
| | | | 2,114 | | | | | | 124 | | | | | | — | | | | | | | | | | | | 2,238 | | |
Accounts receivable
|
| | | | 1,072 | | | | | | — | | | | | | — | | | | | | | | | | | | 1,072 | | |
Total current assets
|
| | | | 11,112 | | | | | | 609 | | | | | | 336,733 | | | | | | | | | | | | 348,454 | | |
Non-current assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Marketable securities held in Trust Account
|
| | | | — | | | | | | 276,947 | | | | | | (276,947) | | | | | | (c) | | | | | | — | | |
Deferred recapitalization costs
|
| | | | 3,173 | | | | | | 1,200 | | | | | | (4,373) | | | | | | (e) | | | | | | — | | |
Investment in joint venture
|
| | | | 200 | | | | | | — | | | | | | — | | | | | | | | | | | | 200 | | |
Other non-current assets
|
| | | | 136 | | | | | | — | | | | | | — | | | | | | | | | | | | 136 | | |
Intangible assets, net
|
| | | | 942 | | | | | | — | | | | | | — | | | | | | | | | | | | 942 | | |
Operating right-of-use asset
|
| | | | 569 | | | | | | — | | | | | | — | | | | | | | | | | | | 569 | | |
Property and equipment, net
|
| | | | 1,674 | | | | | | — | | | | | | — | | | | | | | | | | | | 1,674 | | |
Total assets
|
| | | | 17,806 | | | | | | 278,756 | | | | | | 55,413 | | | | | | | | | | | | 351,975 | | |
Liabilities and Stockholders’ Equity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable and accrued expenses
|
| | | $ | 4,011 | | | | | $ | 1,307 | | | | | $ | — | | | | | | | | | | | $ | 5,318 | | |
Accrued offering costs
|
| | | | — | | | | | | 26 | | | | | | (26) | | | | | | (e) | | | | | | — | | |
Income taxes payable
|
| | | | — | | | | | | 206 | | | | | | — | | | | | | | | | | | | 206 | | |
Deferred revenue
|
| | | | 4,415 | | | | | | — | | | | | | — | | | | | | | | | | | | 4,415 | | |
Operating lease liability, current
|
| | | | 394 | | | | | | — | | | | | | — | | | | | | | | | | | | 394 | | |
Note payable
|
| | | | 1,165 | | | | | | — | | | | | | (1,165) | | | | | | (j) | | | | | | — | | |
Total current liabilities
|
| | | | 9,985 | | | | | | 1,539 | | | | | | (1,191) | | | | | | | | | | | | 10,333 | | |
Non-current liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Deferred underwriting fee payable
|
| | | | — | | | | | | 9,625 | | | | | | (9,625) | | | | | | (e) | | | | | | — | | |
Warrant liabilities
|
| | | | — | | | | | | 37,617 | | | | | | — | | | | | | | | | | | | 37,617 | | |
Operating lease liability, long-term
|
| | | | 125 | | | | | | — | | | | | | — | | | | | | | | | | | | 125 | | |
Total liabilities
|
| | | | 10,110 | | | | | | 48,781 | | | | | | (10,816) | | | | | | | | | | | | 48,075 | | |
Commitments and contingencies: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Class A common stock subject to possible redemption
|
| | | | — | | | | | | 224,976 | | | | | | (36,222) | | | | | | (c) | | | | | | — | | |
| | | | | | | | | | | | | | | | | (188,755) | | | | | | (f) | | | | | | | | |
Stockholders’ Equity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Class A common stock, $0.0001 par value
|
| | | | — | | | | | | — | | | | | | 4 | | | | | | (g) | | | | | | 8 | | |
| | | | | | | | | | | | | | | | | 2 | | | | | | (f) | | | | | | | | |
| | | | | | | | | | | | | | | | | 1 | | | | | | (d) | | | | | | | | |
| | | | | | | | | | | | | | | | | 1 | | | | | | (i) | | | | | | | | |
Class B common stock, $0.0001 par value
|
| | | | — | | | | | | 1 | | | | | | (1) | | | | | | (i) | | | | | | — | | |
Preferred stock – Series Seed, $0.00001 par
|
| | | | — | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Preferred stock – Series A, $0.00001 par value
|
| | | | — | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Preferred stock – Series B, $0.00001 par value
|
| | | | — | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Common stock, $0.00001 par value
|
| | | | — | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Additional paid in capital
|
| | | | 51,416 | | | | | | 24,270 | | | | | | 124,999 | | | | | | (d) | | | | | | 348,172 | | |
| | | | | | | | | | | | | | | | | (4) | | | | | | (g) | | | | | | | | |
| | | | | | | | | | | | | | | | | 188,752 | | | | | | (f) | | | | | | | | |
| | | | | | | | | | | | | | | | | (22,549) | | | | | | (e) | | | | | | | | |
| | | | | | | | | | | | | | | | | (19,272) | | | | | | (h) | | | | | | | | |
| | | | | | | | | | | | | | | | | 559 | | | | | | (k) | | | | | | | | |
Retained earnings (Accumulated deficit)
|
| | | | (43,720) | | | | | | (19,272) | | | | | | 19,272 | | | | | | (h) | | | | | | (44,279) | | |
| | | | | | | | | | | | | | | | | (559) | | | | | | (k) | | | | | | | | |
Total stockholders’ equity
|
| | | | 7,696 | | | | | | 4,999 | | | | | | 291,206 | | | | | | | | | | | | 303,900 | | |
Total Liabilities and Stockholders’ Equity
|
| | | $ | 17,806 | | | | | $ | 278,756 | | | | | $ | 55,413 | | | | | | | | | | | $ | 351,975 | | |
| | |
Historical
Blade |
| |
Historical
EIC |
| |
Pro Forma
Transaction Accounting Adjustments |
| | | | | | | |
Pro Forma
Combined |
| ||||||||||||
| | |
(aa)
|
| |
(bb)
|
| | | | | | | | | | | | | | | | | | | ||||||
Revenue
|
| | | $ | 17,259 | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | 17,259 | | |
Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenue
|
| | | | 13,995 | | | | | | — | | | | | | — | | | | | | | | | | | | 13,995 | | |
Software development
|
| | | | 342 | | | | | | — | | | | | | — | | | | | | | | | | | | 342 | | |
General and administrative
|
| | | | 8,214 | | | | | | 492 | | | | | | — | | | | | | | | | | | | 8,706 | | |
Selling and marketing
|
| | | | 1,301 | | | | | | — | | | | | | — | | | | | | | | | | | | 1,301 | | |
Total operating expenses
|
| | | | 23,852 | | | | | | 492 | | | | | | — | | | | | | | | | | | | 24,344 | | |
Loss from operations
|
| | | | (6,593) | | | | | | (492) | | | | | | — | | | | | | | | | | | | (7,085) | | |
Other non-operating income (expense) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest income
|
| | | | 11 | | | | | | 9 | | | | | | (9) | | | | | | (cc) | | | | | | 11 | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | (19,092) | | | | | | — | | | | | | | | | | | | (19,092) | | |
Total other income (expense)
|
| | | | 11 | | | | | | (19,083) | | | | | | (9) | | | | | | | | | | | | (19,081) | | |
Income (loss) before income taxes
|
| | | | (6,582) | | | | | | (19,575) | | | | | | (9) | | | | | | (cc) | | | | | | (26,166) | | |
Benefit (provision) for income taxes
|
| | | | — | | | | | | (86) | | | | | | 2 | | | | | | | | | | | | (84) | | |
Net income (loss)
|
| | | $ | (6,582) | | | | | $ | (19,661) | | | | | $ | (7) | | | | | | | | | | | $ | (26,250) | | |
Weighted average shares of EIC Class A Common Stock outstanding, basic and diluted
|
| | | | | | | | | | 10,974,301 | | | | | | | | | | | | | | | | | | 78,903,021 | | |
Net loss per share of EIC Class A Common Stock, basic and
diluted |
| | | | | | | | | $ | (1.79) | | | | | | | | | | | | | | | | | $ | (0.33) | | |
Weighted average shares of Legacy Blade Common Stock outstanding, basic and diluted
|
| | | | 12,681,029 | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss per share of Legacy Blade Common Stock, basic and diluted
|
| | | $ | (0.52) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | |
Historical
Blade |
| |
Historical
EIC |
| |
Pro Forma
Transaction Accounting Adjustments |
| | | | | | | |
Pro Forma
Combined |
| ||||||||||||
| | |
(aaa)
|
| |
(bbb)
|
| | | | | | | | | | | | | | | | | | | ||||||
Revenue
|
| | | $ | 23,434 | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | 23,434 | | |
Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenue
|
| | | | 21,107 | | | | | | — | | | | | | — | | | | | | | | | | | | 21,107 | | |
Software development
|
| | | | 861 | | | | | | — | | | | | | — | | | | | | | | | | | | 861 | | |
General and administrative
|
| | | | 9,292 | | | | | | 646 | | | | | | 559 | | | | | | (ddd) | | | | | | 10,497 | | |
Selling and marketing
|
| | | | 2,533 | | | | | | — | | | | | | — | | | | | | | | | | | | 2,533 | | |
Total operating expenses
|
| | | | 33,793 | | | | | | 646 | | | | | | 559 | | | | | | | | | | | | 34,998 | | |
Loss from operations
|
| | | | (10,359) | | | | | | (646) | | | | | | (559) | | | | | | | | | | | | (11,564) | | |
Other non-operating income (expense) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest income
|
| | | | 200 | | | | | | 2,104 | | | | | | (2,104) | | | | | | (ccc) | | | | | | 200 | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | (558) | | | | | | — | | | | | | | | | | | | (558) | | |
Interest expense
|
| | | | (1) | | | | | | — | | | | | | — | | | | | | | | | | | | (1) | | |
Total other income (expense)
|
| | | | 199 | | | | | | 1,546 | | | | | | (2,104) | | | | | | | | | | | | (359) | | |
Income (loss) before income taxes
|
| | | | (10,160) | | | | | | 901 | | | | | | (2,663) | | | | | | | | | | | | (11,923) | | |
Benefit (provision) for income taxes
|
| | | | — | | | | | | (306) | | | | | | 559 | | | | | | (eee) | | | | | | 253 | | |
Net income (loss)
|
| | | $ | (10,160) | | | | | $ | 594 | | | | | $ | (2,104) | | | | | | | | | | | $ | (11,670) | | |
Weighted average shares of EIC Class A Common Stock outstanding, basic and diluted
|
| | | | | | | | | | 8,208,043 | | | | | | | | | | | | | | | | | | 78,903,021 | | |
Net gain per share of EIC Class A Common
Stock, basic and diluted |
| | | | | | | | | $ | 0.07 | | | | | | | | | | | | | | | | | $ | (0.15) | | |
Weighted average shares of Legacy Blade Common Stock outstanding, basic and diluted
|
| | | | 12,512,567 | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss per share of Legacy Blade Common Stock, basic and diluted
|
| | | $ | (0.81) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | |
Year Ended
December 31, 2020 |
| |
Nine Months
Ended September 30, 2020 |
| |
Three Months
Ended March 31, 2021 |
| |
Six Months
Ended March 31, 2021 |
| ||||||||||||
Operating and formation costs
|
| | | $ | 678 | | | | | $ | 421 | | | | | $ | 235 | | | | | $ | 492 | | |
Loss from operations
|
| | | | (678) | | | | | | (421) | | | | | | (235) | | | | | | (492) | | |
Other income: | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest income on marketable securities held in Trust Account
|
| | | | 1,016 | | | | | | 1,011 | | | | | | 4 | | | | | | 9 | | |
Change in fair value of warrant liabilities
|
| | | | (20,650) | | | | | | (2,408) | | | | | | (850) | | | | | | (19,092) | | |
Loss before income taxes
|
| | | | (20,312) | | | | | | (1,818) | | | | | | (1,081) | | | | | | (19,575) | | |
Provision for income taxes
|
| | | | (210) | | | | | | (124) | | | | | | — | | | | | | (86) | | |
Net loss
|
| | | $ | (20,522) | | | | | $ | (1,942) | | | | | $ | (1,081) | | | | | $ | (19,661) | | |
(in thousands)
|
| |
Nine Months
Ended September 30, 2020 |
| |
For the Period
from May 24, 2019 (inception) through December 31, 2019 |
| |
For the Period
from May 24, 2019 (inception) through September 30, 2019 |
| |
Twelve
Months Ended September 30, 2020 |
| ||||||||||||
Formation and operating costs. .
|
| | | $ | 421 | | | | | $ | 268 | | | | | $ | 44 | | | | | $ | 646 | | |
Transaction costs
|
| | | | — | | | | | | 637 | | | | | | 637 | | | | | | — | | |
Loss from operations
|
| | | | (421) | | | | | | (905) | | | | | | (681) | | | | | | (646) | | |
Other income: | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest income on marketable securities held in Trust Account
|
| | | | 1,011 | | | | | | 1,262 | | | | | | 168 | | | | | | 2,104 | | |
Change in fair value of warrant liabilities
|
| | | | (2,408) | | | | | | 2,183 | | | | | | 333 | | | | | | (558) | | |
(Loss) income before income taxes
|
| | | | (1,819) | | | | | | 2,540 | | | | | | (179) | | | | | | 901 | | |
Provision for income taxes
|
| | | | (124) | | | | | | (209) | | | | | | (26) | | | | | | (306) | | |
Net (loss) income
|
| | | $ | (1,942) | | | | | $ | 2,331 | | | | | $ | (205) | | | | | $ | 594 | | |
| | |
Three Months Ended March 31,
|
| |
Six Months Ended March 31,
|
| ||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2021
|
| |
2020
|
| ||||||||||||
Seats flown – all flights
|
| | | | 2,936 | | | | | | 4,988 | | | | | | 5,882 | | | | | | 12,278 | | |
| | |
Three Months Ended March 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||
| | |
$
|
| |
% of Revenue
|
| |
$
|
| |
% of Revenue
|
| ||||||||||||
Revenue
|
| | | | 9,273 | | | | | | 100 | | | | | | 6,454 | | | | | | 100 | | |
Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenue
|
| | | | 7,673 | | | | | | 83 | | | | | | 5,831 | | | | | | 90 | | |
Software development
|
| | | | 156 | | | | | | 2 | | | | | | 241 | | | | | | 4 | | |
General and administrative
|
| | | | 4,803 | | | | | | 52 | | | | | | 2,807 | | | | | | 43 | | |
Selling and marketing
|
| | | | 866 | | | | | | 9 | | | | | | 923 | | | | | | 14 | | |
Total operating expenses
|
| | | | 13,498 | | | | | | 146 | | | | | | 9,802 | | | | | | 152 | | |
Loss from operations
|
| | | | (4,225) | | | | | | | | | | | | (3,348) | | | | | | | | |
Other non-operating income (expense) | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest income (expense)
|
| | | | 4 | | | | | | | | | | | | (61) | | | | | | | | |
Total other non-operating income (expense)
|
| | | | 4 | | | | | | | | | | | | (61) | | | | | | | | |
Net loss
|
| | | | (4,221) | | | | | | | | | | | | (3,409) | | | | | | | | |
| | |
For the Three Months Ended
March 31, |
| |||||||||
Product Line
|
| |
2021
|
| |
2020
|
| ||||||
Short distance
|
| | | $ | 1,049 | | | | | $ | 1,787 | | |
MediMobility organ transport and jet
|
| | | | 7,729 | | | | | | 4,588 | | |
Other
|
| | | | 495 | | | | | | 79 | | |
Total Revenue
|
| | | $ | 9,273 | | | | | $ | 6,454 | | |
| | |
Six Months Ended March 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||
| | |
$
|
| |
% of Revenue
|
| |
$
|
| |
% of Revenue
|
| ||||||||||||
Revenue
|
| | | | 17,259 | | | | | | 100 | | | | | | 11,677 | | | | | | 100 | | |
Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenue
|
| | | | 13,995 | | | | | | 81 | | | | | | 11,588 | | | | | | 99 | | |
Software development
|
| | | | 342 | | | | | | 2 | | | | | | 471 | | | | | | 4 | | |
General and administrative
|
| | | | 8,214 | | | | | | 48 | | | | | | 5,815 | | | | | | 50 | | |
Selling and marketing
|
| | | | 1,301 | | | | | | 8 | | | | | | 1,955 | | | | | | 17 | | |
| | |
Six Months Ended March 31,
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||
| | |
$
|
| |
% of Revenue
|
| |
$
|
| |
% of Revenue
|
| ||||||||||||
Total operating expenses
|
| | | | 23,852 | | | | | | 138 | | | | | | 19,829 | | | | | | 170 | | |
Loss from operations
|
| | | | (6,593) | | | | | | | | | | | | (8,152) | | | | | | | | |
Other non-operating income | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest income
|
| | | | 11 | | | | | | | | | | | | 30 | | | | | | | | |
Total other non-operating income
|
| | | | 11 | | | | | | | | | | | | 30 | | | | | | | | |
Net loss
|
| | | | (6,582) | | | | | | | | | | | | (8,122) | | | | | | | | |
|
| | |
For the Six Months Ended
March 31, |
| |||||||||
Product Line
|
| |
2021
|
| |
2020
|
| ||||||
Short distance
|
| | | $ | 3,179 | | | | | $ | 5,138 | | |
MediMobility organ transport and jet
|
| | | | 13,253 | | | | | | 6,453 | | |
Other
|
| | | | 827 | | | | | | 86 | | |
Total Revenue
|
| | | $ | 17,259 | | | | | $ | 11,677 | | |
| | |
Years Ended September 30,
|
| |||||||||||||||||||||
| | |
2020
|
| |
2019
|
| ||||||||||||||||||
($ in thousands)
|
| |
$
|
| |
% of
2020 Revenue |
| |
$
|
| |
% of
2019 Revenue |
| ||||||||||||
Revenue
|
| | | | 23,434 | | | | | | 100 | | | | | | 31,196 | | | | | | 100 | | |
Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenue
|
| | | | 21,107 | | | | | | 90 | | | | | | 26,497 | | | | | | 85 | | |
Development costs
|
| | | | 861 | | | | | | 4 | | | | | | 751 | | | | | | 2 | | |
General and administrative
|
| | | | 9,292 | | | | | | 40 | | | | | | 10,476 | | | | | | 34 | | |
Selling and marketing
|
| | | | 2,533 | | | | | | 11 | | | | | | 5,013 | | | | | | 16 | | |
Total operating expenses
|
| | | | 33,793 | | | | | | 144 | | | | | | 42,737 | | | | | | 137 | | |
Loss from operations
|
| | | | (10,359) | | | | | | | | | | | | (11,541) | | | | | | | | |
Other non-operating income (expense) | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest income
|
| | | | 200 | | | | | | | | | | | | 718 | | | | | | | | |
Interest expense
|
| | | | (1) | | | | | | | | | | | | (15) | | | | | | | | |
Total other income
|
| | | | 199 | | | | | | | | | | | | 703 | | | | | | | | |
Net loss
|
| | | | (10,160) | | | | | | | | | | | | (10,838) | | | | | | | | |
| | |
Six Months Ended March 31,
|
| |
Change
|
| ||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
$
|
| |
%
|
| ||||||||||||
Net cash used in operating activities
|
| | | $ | (607) | | | | | $ | (9,344) | | | | | $ | 8,737 | | | | | | (94) | | |
Net cash used in investing activities
|
| | | | (589) | | | | | | (368) | | | | | | (221) | | | | | | 60 | | |
Net cash (used in) provided by financing activities
|
| | | | (3,154) | | | | | | 5 | | | | | | (3,159) | | | | | | (63,180) | | |
Net decrease in cash, cash equivalents and
restricted cash |
| | | $ | (4,350) | | | | | $ | (9,707) | | | | | $ | 5,357 | | | | | | (55) | | |
| | |
Years Ended September 30
|
| |||||||||||||||||||||
($ in thousands)
|
| |
2020
|
| |
2019
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
Net cash used in operating activities
|
| | | $ | (10,818) | | | | | $ | (10,302) | | | | | | (516) | | | | | | 5.0 | | |
Net cash used in investing activities
|
| | | | (377) | | | | | | (1,054) | | | | | | 677 | | | | | | (64.2) | | |
Net cash provided by financing activities
|
| | | | 1,180 | | | | | | 116 | | | | | | 1,064 | | | | | | 917.2 | | |
Net increase (decrease) in cash, cash equivalents and restricted cash
|
| | | $ | (10,015) | | | | | $ | (11,240) | | | | | | 1,225 | | | | | | (10.9) | | |
Name
|
| |
Age
|
| |
Title
|
| |||
Robert S. Wiesenthal | | | | | 54 | | | | Chief Executive Officer and Director | |
William A. Heyburn | | | | | 32 | | | |
Chief Financial Officer and Head of Corporate Development
|
|
Melissa M. Tomkiel | | | | | 41 | | | | President and General Counsel | |
Brandon Keene | | | | | 35 | | | | Chief Technology Officer | |
Amir Cohen | | | | | 45 | | | | Chief Accounting Officer | |
Eric Affeldt | | | | | 63 | | | | Chairman of the Board | |
Jane Garvey | | | | | 77 | | | | Director | |
Kenneth Lerer | | | | | 69 | | | | Director | |
Susan Lyne | | | | | 71 | | | | Director | |
Edward Philip | | | | | 56 | | | | Director | |
David Zaslav | | | | | 61 | | | | Director | |
Name and Principal Position
|
| |
Year
|
| |
Salary
|
| |
Option
awards(1) |
| |
All other
compensation(2) |
| |
Total
compensation |
| ||||||||||||
Robert S. Wiesenthal
|
| |
2020
|
| | | | 350,000 | | | | | | 202,021 | | | | | | 3,137 | | | | | | 555,157 | | |
Chief Executive Officer
|
| |
2019
|
| | | | 350,000 | | | | | | 853,673 | | | | | | — | | | | | | 1,203,673 | | |
Melissa M. Tomkiel
|
| |
2020
|
| | | | 275,000 | | | | | | 86,107 | | | | | | — | | | | | | 361,107 | | |
President and General Counsel
|
| |
2019
|
| | | | 256,251 | | | | | | 55,939 | | | | | | — | | | | | | 312,190 | | |
William A. Heyburn
|
| |
2020
|
| | | | 200,000 | | | | | | 57,756 | | | | | | 60 | | | | | | 257,815 | | |
Chief Financial Officer and Head of Corporate
|
| |
2019
|
| | | | 153,125 | | | | | | 101,096 | | | | | | — | | | | | | 254,221 | | |
Development
|
| | | | | | | |
| | | | | |
Option Awards(11)
|
| ||||||||||||||||||
Name
|
| |
Grant Date
|
| |
Number of Securities
Underlying Unexercised Options (#) Exercisable |
| |
Number of Securities
Underlying Unexercised Options (#) Unexercisable |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date |
| |||||||||
Robert S. Wiesenthal
|
| |
4/10/2015
|
| | | | 3,400,000 | | | | | | 0 | | | | | | 0.13 | | | |
4/10/2025
|
|
| | |
9/1/2015
|
| | | | 388,005 | | | | | | 0 | | | | | | 0.13 | | | |
9/1/2025
|
|
| | |
11/16/2018
|
| | | | 1,529,044 | | | | | | 1,807,051(1) | | | | | | 0.13 | | | |
11/16/2028
|
|
Melissa M. Tomkiel
|
| |
4/10/2015
|
| | | | 430,171 | | | | | | 0 | | | | | | 0.13 | | | |
4/10/2025
|
|
| | |
6/27/2017
|
| | | | 218,656 | | | | | | 37,331(2) | | | | | | 0.13 | | | |
6/27/2027
|
|
| | |
11/16/2018
|
| | | | 102,223 | | | | | | 57,777(3) | | | | | | 0.13 | | | |
11/16/2028
|
|
| | |
7/11/2019
|
| | | | 17,188 | | | | | | 37,812(4) | | | | | | 0.13 | | | |
7/11/2029
|
|
| | |
7/28/2020
|
| | | | 0 | | | | | | 208,842(5) | | | | | | 0.13 | | | |
7/28/2030
|
|
| | |
7/28/2020
|
| | | | 0 | | | | | | 640,000(6) | | | | | | 0.13 | | | |
7/28/2030
|
|
William A. Heyburn
|
| |
11/16/2018
|
| | | | 77,752 | | | | | | 50,940(7) | | | | | | 0.13 | | | |
11/16/2028
|
|
| | |
7/11/2019
|
| | | | 83,334 | | | | | | 166,666(8) | | | | | | 0.13 | | | |
7/11/2029
|
|
| | |
7/28/2020
|
| | | | 0 | | | | | | 46,308(9) | | | | | | 0.13 | | | |
7/28/2030
|
|
| | |
7/28/2020
|
| | | | 0 | | | | | | 560,000(10) | | | | | | 0.13 | | | |
7/28/2030
|
|
Name of Beneficial Owners(1)
|
| |
Number of
Shares of Class A Common Stock Beneficially Owned(2) |
| |
Percentage
of Outstanding Class A Common Stock |
| ||||||
5% Stockholders: | | | | | | | | | | | | | |
Experience Sponsor LLC(3)
|
| | | | 13,880,000 | | | | | | 18.7% | | |
Robert S. Wiesenthal(4)
|
| | | | 10,108,983 | | | | | | 13.6% | | |
HG Vora Capital Management, LLC(5)
|
| | | | 7,876,453 | | | | | | 11.4% | | |
Colony Capital, Inc.(6)
|
| | | | 5,153,835 | | | | | | 7.4% | | |
Executive Officers and Directors: | | | | | | | | | | | | | |
Eric Affeldt(7)
|
| | | | — | | | | | | — | | |
Jane Garvey
|
| | | | — | | | | | | — | | |
Kenneth Lerer(8)
|
| | | | 1,235,349 | | | | | | 1.8% | | |
Susan Lyne
|
| | | | — | | | | | | — | | |
Edward Philip(7)
|
| | | | — | | | | | | — | | |
David Zaslav(9)
|
| | | | 3,082,262 | | | | | | 4.5% | | |
Robert S. Wiesenthal(4)
|
| | | | 10,108,983 | | | | | | 13.6% | | |
William A. Heyburn(10)
|
| | | | 935,489 | | | | | | 1.3% | | |
Melissa M. Tomkiel(11)
|
| | | | 1,495,937 | | | | | | 2.1% | | |
Amir Cohen
|
| | | | — | | | | | | — | | |
Brandon Keene(12)
|
| | | | 520,524 | | | | | | *% | | |
All directors and executive officers as a group (11 individuals)(13)
|
| | | | 17,378,544 | | | | | | 22.6% | | |
| | |
Class A
Common Stock |
| |
Private
Placement Warrants |
| ||||||
Eric Affeldt
|
| | | | 605,250 | | | | | | 350,000 | | |
Brian C. Witherow
|
| | | | 50,000 | | | | | | — | | |
Rafael Pastor
|
| | | | 50,000 | | | | | | — | | |
Edward Philip
|
| | | | 50,000 | | | | | | — | | |
| | |
Securities Beneficially
Owned Prior to this Offering |
| |
Securities to be
Sold in this Offering(1) |
| |
Securities Beneficially
Owned After this Offering |
| |||||||||||||||||||||||||||||||||||||||
Selling Securityholder
|
| |
Shares of
Class A Common Stock(2) |
| |
Private
Placement Warrants |
| |
Shares of
Class A Common Stock(2) |
| |
Private
Placement Warrants |
| |
Shares of
Class A Common Stock(2) |
| |
%
|
| |
Private
Placement Warrants |
| |
%
|
| ||||||||||||||||||||||||
Alyeska Master Fund L.P.(3)
|
| | | | 500,000 | | | | | | — | | | | | | 500,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Arrow 1999 Trust(4)
|
| | | | 491,616 | | | | | | — | | | | | | 100,000 | | | | | | — | | | | | | 391,616 | | | | |
|
*
|
| | | | | — | | | | | | — | | |
| | |
Securities Beneficially
Owned Prior to this Offering |
| |
Securities to be
Sold in this Offering(1) |
| |
Securities Beneficially
Owned After this Offering |
| |||||||||||||||||||||||||||||||||||||||
Selling Securityholder
|
| |
Shares of
Class A Common Stock(2) |
| |
Private
Placement Warrants |
| |
Shares of
Class A Common Stock(2) |
| |
Private
Placement Warrants |
| |
Shares of
Class A Common Stock(2) |
| |
%
|
| |
Private
Placement Warrants |
| |
%
|
| ||||||||||||||||||||||||
BEMAP Master Fund Ltd(5)
|
| | | | 152,969 | | | | | | — | | | | | | 152,969 | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
Bespoke Alpha MAC
MIM LP(5) |
| | | | 18,633 | | | | | | — | | | | | | 18,633 | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
Broadfin Advisors
Privates LLC(6) |
| | | | 100,000 | | | | | | — | | | | | | 100,000 | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
Citadel Multi-Strategy Equities Master Fund Ltd.(7)
|
| | | | 250,000 | | | | | | — | | | | | | 250,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Dave Portnoy(8)
|
| | | | 200,000 | | | | | | — | | | | | | 200,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
DG Value Partners, LP(9)
|
| | | | 38,040 | | | | | | — | | | | | | 38,040 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
DG Value Partners II Master
Fund LP(9) |
| | | | 211,960 | | | | | | — | | | | | | 211,960 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
DS Liquid Div RVA MON LLC(5)
|
| | | | 124,140 | | | | | | — | | | | | | 124,140 | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
HBK Master Fund L.P.(10)
|
| | | | 500,000 | | | | | | — | | | | | | 500,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Hedosophia Public Investments Limited(11)
|
| | | | 2,000,000 | | | | | | — | | | | | | 2,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
HG Vora Opportunistic Capital Master Fund LP(12)
|
| | | | 1,899,993 | | | | | | — | | | | | | 1,484,245 | | | | | | — | | | | | | 415,748 | | | | |
|
*
|
| | | | | — | | | | | | — | | |
HG Vora Special Opportunities Master Fund, Ltd(12)
|
| | | | 5,976,460 | | | | | | — | | | | | | 2,715,755 | | | | | | — | | | | | | 3,260,705 | | | | | | 4.7% | | | | | | — | | | | | | — | | |
Ithaka Trust(13)
|
| | | | 200,000 | | | | | | — | | | | | | 200,000 | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
Legacy Worldwide Investments II Ltd.(14)
|
| | | | 200,000 | | | | | | — | | | | | | 200,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Maven III, LLC(15)
|
| | | | 100,000 | | | | | | — | | | | | | 100,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Monashee Pure Alpha SPV I
LP(5) |
| | | | 85,589 | | | | | | — | | | | | | 85,589 | | | | | | — | | | | |
|
—
|
| | | | | — | | | | |
|
—
|
| | | | | — | | |
Monashee Solitario
Fund LP(5) |
| | | | 93,812 | | | | | | — | | | | | | 93,812 | | | | | | — | | | | |
|
—
|
| | | | | — | | | | |
|
—
|
| | | | | — | | |
MYDA Advantage, LP(16)
|
| | | | 125,000 | | | | | | — | | | | | | 125,000 | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
MYDA SPAC Select, LP(16)
|
| | | | 125,000 | | | | | | — | | | | | | 125,000 | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
RB Lift LLC(17)
|
| | | | 800,000 | | | | | | — | | | | | | 800,000 | | | | |
|
—
|
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Richard Sherman Trust(18)
|
| | | | 10,000 | | | | | | — | | | | | | 10,000 | | | | | | — | | | | |
|
—
|
| | | | | — | | | | |
|
—
|
| | | | | — | | |
Robert W. Pittman(19)
|
| | | | 130,203 | | | | | | — | | | | | | 10,000 | | | | | | — | | | | | | 120,203 | | | | |
|
*
|
| | | | | — | | | | | | — | | |
SFL SPV I LLC(5)
|
| | | | 24,857 | | | | | | — | | | | | | 24,857 | | | | | | — | | | | |
|
—
|
| | | | | — | | | | |
|
—
|
| | | | | — | | |
Steele ExpCo Holdings,
LLC(20) |
| | | | 2,005,000 | | | | | | — | | | | | | 2,005,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Tech Opportunities LLC(21)
|
| | | | 200,000 | | | | | | — | | | | | | 200,000 | | | | | | — | | | | |
|
—
|
| | | | | — | | | | |
|
—
|
| | | | | — | | |
The David B. Fischer Revocable Trust(22)
|
| | | | 25,000 | | | | | | — | | | | | | 25,000 | | | | | | — | | | | |
|
—
|
| | | | | — | | | | |
|
—
|
| | | | | — | | |
| | |
Securities Beneficially
Owned Prior to this Offering |
| |
Securities to be
Sold in this Offering(1) |
| |
Securities Beneficially
Owned After this Offering |
| |||||||||||||||||||||||||||||||||||||||
Selling Securityholder
|
| |
Shares of
Class A Common Stock(2) |
| |
Private
Placement Warrants |
| |
Shares of
Class A Common Stock(2) |
| |
Private
Placement Warrants |
| |
Shares of
Class A Common Stock(2) |
| |
%
|
| |
Private
Placement Warrants |
| |
%
|
| ||||||||||||||||||||||||
Experience Sponsor LLC(20)
|
| | | | 11,875,000 | | | | | | 5,000,000 | | | | | | 11,875,000 | | | | | | 5,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Rob Wiesenthal(23)
|
| | | | 10,108,983 | | | | | | — | | | | | | 10,108,983 | | | | | | — | | | | |
|
—
|
| | | | | — | | | | | | — | | | | | | — | | |
ColPE Blade Investor, LLC(24)
|
| | | | 5,153,835 | | | | | | — | | | | | | 5,153,835 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
JustBlade, LLC(25)
|
| | | | 463,844 | | | | | | — | | | | | | 463,844 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Lerer Investments II LLC(26)
|
| | | | 111,500 | | | | | | — | | | | | | 111,500 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Lerer Hippeau Ventures Select Fund LP(26)
|
| | | | 373,988 | | | | | | — | | | | | | 373,988 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Lerer Hippeau Ventures V, L.P.(26)
|
| | | | 698,901 | | | | | | — | | | | | | 698,901 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Kenneth Lerer(27)
|
| | | | 50,960 | | | | | | — | | | | | | 50,960 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Brandon Keene(28)
|
| | | | 520,524 | | | | | | — | | | | | | 520,524 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Melissa M. Tomkiel(29)
|
| | | | 1,495,937 | | | | | | — | | | | | | 1,495,937 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
William A. Heyburn(30)
|
| | | | 935,489 | | | | | | — | | | | | | 935,489 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Snickers Holdings LLC(31)
|
| | | | 3,092,262 | | | | | | — | | | | | | 3,092,262 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Eric Affeldt(32)
|
| | | | 10,000 | | | | | | — | | | | | | 10,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | |
Fair Market Value of Class A common stock
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Redemption Date (Period to Expiration of
Public Warrants) |
| |
$10.00
|
| |
$11.00
|
| |
$12.00
|
| |
$13.00
|
| |
$14.00
|
| |
$15.00
|
| |
$16.00
|
| |
$17.00
|
| |
$18.00
|
| |||||||||||||||||||||||||||
57 months
|
| | | | 0.257 | | | | | | 0.277 | | | | | | 0.294 | | | | | | 0.310 | | | | | | 0.324 | | | | | | 0.337 | | | | | | 0.348 | | | | | | 0.358 | | | | | | 0.365 | | |
54 months
|
| | | | 0.252 | | | | | | 0.272 | | | | | | 0.291 | | | | | | 0.307 | | | | | | 0.322 | | | | | | 0.335 | | | | | | 0.347 | | | | | | 0.357 | | | | | | 0.365 | | |
51 months
|
| | | | 0.246 | | | | | | 0.268 | | | | | | 0.287 | | | | | | 0.304 | | | | | | 0.320 | | | | | | 0.333 | | | | | | 0.346 | | | | | | 0.357 | | | | | | 0.365 | | |
48 months
|
| | | | 0.241 | | | | | | 0.263 | | | | | | 0.283 | | | | | | 0.301 | | | | | | 0.317 | | | | | | 0.332 | | | | | | 0.344 | | | | | | 0.356 | | | | | | 0.365 | | |
45 months
|
| | | | 0.235 | | | | | | 0.258 | | | | | | 0.279 | | | | | | 0.298 | | | | | | 0.315 | | | | | | 0.330 | | | | | | 0.343 | | | | | | 0.356 | | | | | | 0.365 | | |
42 months
|
| | | | 0.228 | | | | | | 0.252 | | | | | | 0.274 | | | | | | 0.294 | | | | | | 0.312 | | | | | | 0.328 | | | | | | 0.342 | | | | | | 0.355 | | | | | | 0.364 | | |
39 months
|
| | | | 0.221 | | | | | | 0.246 | | | | | | 0.269 | | | | | | 0.290 | | | | | | 0.309 | | | | | | 0.325 | | | | | | 0.340 | | | | | | 0.354 | | | | | | 0.364 | | |
36 months
|
| | | | 0.213 | | | | | | 0.239 | | | | | | 0.263 | | | | | | 0.285 | | | | | | 0.305 | | | | | | 0.323 | | | | | | 0.339 | | | | | | 0.353 | | | | | | 0.364 | | |
33 months
|
| | | | 0.205 | | | | | | 0.232 | | | | | | 0.257 | | | | | | 0.280 | | | | | | 0.301 | | | | | | 0.320 | | | | | | 0.337 | | | | | | 0.352 | | | | | | 0.364 | | |
30 months
|
| | | | 0.196 | | | | | | 0.224 | | | | | | 0.250 | | | | | | 0.274 | | | | | | 0.297 | | | | | | 0.316 | | | | | | 0.335 | | | | | | 0.351 | | | | | | 0.364 | | |
27 months
|
| | | | 0.185 | | | | | | 0.214 | | | | | | 0.242 | | | | | | 0.268 | | | | | | 0.291 | | | | | | 0.313 | | | | | | 0.332 | | | | | | 0.350 | | | | | | 0.364 | | |
24 months
|
| | | | 0.173 | | | | | | 0.204 | | | | | | 0.233 | | | | | | 0.260 | | | | | | 0.285 | | | | | | 0.308 | | | | | | 0.329 | | | | | | 0.348 | | | | | | 0.364 | | |
21 months
|
| | | | 0.161 | | | | | | 0.193 | | | | | | 0.223 | | | | | | 0.252 | | | | | | 0.279 | | | | | | 0.304 | | | | | | 0.326 | | | | | | 0.347 | | | | | | 0.364 | | |
18 months
|
| | | | 0.146 | | | | | | 0.179 | | | | | | 0.211 | | | | | | 0.242 | | | | | | 0.271 | | | | | | 0.298 | | | | | | 0.322 | | | | | | 0.345 | | | | | | 0.363 | | |
15 months
|
| | | | 0.130 | | | | | | 0.164 | | | | | | 0.197 | | | | | | 0.230 | | | | | | 0.262 | | | | | | 0.291 | | | | | | 0.317 | | | | | | 0.342 | | | | | | 0.363 | | |
12 months
|
| | | | 0.111 | | | | | | 0.146 | | | | | | 0.181 | | | | | | 0.216 | | | | | | 0.250 | | | | | | 0.282 | | | | | | 0.312 | | | | | | 0.339 | | | | | | 0.363 | | |
9 months
|
| | | | 0.090 | | | | | | 0.125 | | | | | | 0.162 | | | | | | 0.199 | | | | | | 0.237 | | | | | | 0.272 | | | | | | 0.305 | | | | | | 0.336 | | | | | | 0.362 | | |
6 months
|
| | | | 0.065 | | | | | | 0.099 | | | | | | 0.137 | | | | | | 0.178 | | | | | | 0.219 | | | | | | 0.259 | | | | | | 0.296 | | | | | | 0.331 | | | | | | 0.362 | | |
3 months
|
| | | | 0.034 | | | | | | 0.065 | | | | | | 0.104 | | | | | | 0.150 | | | | | | 0.197 | | | | | | 0.243 | | | | | | 0.286 | | | | | | 0.326 | | | | | | 0.361 | | |
0 months
|
| | | | — | | | | | | — | | | | | | 0.042 | | | | | | 0.115 | | | | | | 0.179 | | | | | | 0.233 | | | | | | 0.281 | | | | | | 0.323 | | | | | | 0.361 | | |
| | |
Number
|
| |||
| | | | F-2 | | | |
| | | | F-3 | | | |
| | | | F-4 | | | |
| | | | F-5 | | | |
| | | | F-6 | | | |
| | | | F-7 | | |
| | |
Number
|
| |||
| | | | F-25 | | | |
| | | | F-26 | | | |
| | | | F-27 | | | |
| | | | F-28 | | | |
| | | | F-29 | | |
| | |
Number
|
| |||
| | | | F-41 | | | |
| | | | F-42 | | | |
| | | | F-43 | | | |
| | | | F-44 | | | |
| | | | F-45 | | | |
| | | | F-46 | | | |
| | | | F-68 | | | |
| | | | F-69 | | | |
| | | | F-70 | | | |
| | | | F-71 | | | |
| | | | F-72 | | |
| | |
December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
| | |
(As Restated)
|
| |
(As Restated)
|
| ||||||
ASSETS | | | | | | | | | | | | | |
Current Assets | | | | | | | | | | | | | |
Cash
|
| | | $ | 846,068 | | | | | $ | 1,305,608 | | |
Prepaid expenses
|
| | | | 50,000 | | | | | | 125,000 | | |
Total Current Assets
|
| | | | 896,068 | | | | | | 1,430,608 | | |
Marketable securities held in Trust Account
|
| | | | 276,943,339 | | | | | | 276,261,596 | | |
TOTAL ASSETS
|
| | | $ | 277,839,407 | | | | | $ | 277,692,204 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | |
Current Liabilities | | | | | | | | | | | | | |
Accounts payable and accrued expenses
|
| | | $ | 158,947 | | | | | $ | 136,694 | | |
Accrued offering costs
|
| | | | 26,000 | | | | | | 26,000 | | |
Income taxes payable
|
| | | | 205,844 | | | | | | 208,612 | | |
Total Current Liabilities
|
| | | | 390,791 | | | | | | 371,306 | | |
Deferred underwriting fee payable
|
| | | | 9,625,000 | | | | | | 9,625,000 | | |
Warrant Liabilities
|
| | | | 36,766,667 | | | | | | 16,116,667 | | |
Total Liabilities
|
| | | | 46,782,458 | | | | | | 26,112,973 | | |
Commitments and Contingencies (Note 6) | | | | | | | | | | | | | |
Class A common stock subject to possible redemption 22,480,341 and 24,574,700 shares at redemption value as of December 31, 2020 and 2019, respectively
|
| | | | 226,056,939 | | | | | | 246,579,223 | | |
Stockholders’ Equity | | | | | | | | | | | | | |
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued
and outstanding |
| | | | — | | | | | | — | | |
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 5,019,659 and 2,925,300 shares issued and outstanding (excluding 22,480,341 and 24,574,700 shares subject to possible redemption) as of December 31, 2020 and 2019, respectively
|
| | | | 502 | | | | | | 293 | | |
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 6,875,000 shares issued and outstanding as of December 31, 2020 and 2019
|
| | | | 688 | | | | | | 688 | | |
Additional paid-in capital
|
| | | | 23,189,660 | | | | | | 2,667,585 | | |
Retained Earnings (Accumulated Deficit)
|
| | | | (18,190,840) | | | | | | 2,331,442 | | |
Total Stockholders’ Equity
|
| | | | 5,000,010 | | | | | | 5,000,008 | | |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
| | | $ | 277,839,407 | | | | | $ | 277,692,204 | | |
| | |
Year Ended
December 31, |
| |
For the Period
from May 24, 2019 (Inception) through December 31, |
| ||||||
| | |
2020
|
| |
2019
|
| ||||||
| | |
(As Restated)
|
| |
(As Restated)
|
| ||||||
Operating costs
|
| | | $ | 678,487 | | | | | $ | 904,875 | | |
Loss from operations
|
| | | | (678,487) | | | | | | (904,875) | | |
Other income: | | | | | | | | | | | | | |
Interest income on marketable securities held in Trust Account
|
| | | | 1,016,670 | | | | | | 1,261,596 | | |
Change in fair value of warrant liabilities
|
| | | | (20,650,000) | | | | | | 2,183,333 | | |
Income (loss) before income taxes
|
| | | | (20,311,817) | | | | | | 2,540,054 | | |
Provision for income taxes
|
| | | | (210,465) | | | | | | (208,612) | | |
Net income (loss)
|
| | | $ | (20,522,282) | | | | | $ | 2,331,442 | | |
Basic and diluted weighted average shares outstanding, Common stock subject
to possible redemption |
| | | | 24,689,816 | | | | | | 24,387,850 | | |
Basic and diluted net income per share, Common stock subject to possible redemption
|
| | | $ | 0.02 | | | | | $ | 0.03 | | |
Basic and diluted weighted average shares outstanding, Common stock
|
| | | | 9,685,184 | | | | | | 8,025,569 | | |
Basic and diluted net loss per common share, common stock
|
| | | $ | (2.17) | | | | | $ | 0.19 | | |
| | |
Class A
Common Stock |
| |
Class B
Common Stock |
| |
Additional
Paid-in Capital |
| |
Retained
Earnings |
| |
Total
Stockholders’ Equity |
| |||||||||||||||||||||||||||
|
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||
Balance – May 24, 2019 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Issuance of Founder Shares to Sponsor
|
| | | | — | | | | | | — | | | | | | 7,187,500 | | | | | | 719 | | | | | | 24,281 | | | | | | — | | | | | | 25,000 | | |
Forfeiture of Founder
Shares |
| | | | — | | | | | | — | | | | | | (312,500) | | | | | | (31) | | | | | | 31 | | | | | | — | | | | | | — | | |
Sale of 27,500,000 Units, net of underwriting discount and offering expenses
|
| | | | 27,500,000 | | | | | | 2,750 | | | | | | — | | | | | | — | | | | | | 241,720,039 | | | | | | — | | | | | | 241,722,789 | | |
Sale of 5,000,000 Private Placement Warrants
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,500,000 | | | | | | — | | | | | | 7,500,000 | | |
Class A common stock subject to possible redemption
|
| | | | (24,574,700) | | | | | | (2,457) | | | | | | — | | | | | | — | | | | | | (246,576,766) | | | | | | — | | | | | | (246,579,223) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,331,442 | | | | | | 2,332,442 | | |
Balance – December 31, 2019
|
| | | | 2,925,300 | | | | | | 293 | | | | | | 6,875,000 | | | | | | 688 | | | | | | 2,667,585 | | | | | | 2,331,442 | | | | | | 5,000,008 | | |
Change in value of Class A common stock subject to possible
redemption |
| | | | 2,094,359 | | | | | | 209 | | | | | | — | | | | | | — | | | | | | 20,522,075 | | | | | | — | | | | | | 20,522,284 | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (20,522,282) | | | | | | (20,522,282) | | |
Balance – December 31, 2020
|
| | | | 5,019,659 | | | | | $ | 502 | | | | | | 6,875,500 | | | | | $ | 688 | | | | | $ | 23,189,660 | | | | | $ | (18,190,840) | | | | | $ | 5,000,010 | | |
| | |
Year Ended
December 31, |
| |
For the Period
from May 24, 2019 (Inception) Through December 31, |
| ||||||
| | |
2020
|
| |
2019
|
| ||||||
| | |
(As Restated)
|
| |
(As Restated)
|
| ||||||
Cash Flows from Operating Activities: | | | | | | | | | | | | | |
Net income
|
| | | $ | (20,522,282) | | | | | $ | 2,331,442 | | |
Adjustments to reconcile net income to net cash used in operating activities:
|
| | | | | | | | | | | | |
Interest earned on marketable securities held in Trust Account
|
| | | | (1,016,670) | | | | | | (1,261,596) | | |
Change in fair value of warrant liabilities
|
| | | | 20,650,000 | | | | | | (2,183,333) | | |
Transaction costs allocable to warrant liabilities
|
| | | | — | | | | | | 636,669 | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Prepaid expenses
|
| | | | 75,000 | | | | | | (125,000) | | |
Accounts payable and accrued expenses
|
| | | | 22,253 | | | | | | 136,694 | | |
Income taxes payable
|
| | | | (2,768) | | | | | | 208,612 | | |
Net cash used in operating activities
|
| | | | (794,467) | | | | | | (256,512) | | |
Cash Flows from Investing Activities: | | | | | | | | | | | | | |
Investment of cash in Trust Account
|
| | | | — | | | | | | (275,000,000) | | |
Cash withdrawn from Trust Account to pay franchise and income taxes
|
| | | | 334,927 | | | | | | — | | |
Net cash provided by (used in) investing activities
|
| | | | 334,927 | | | | | | (275,000,000) | | |
Cash Flows from Financing Activities: | | | | | | | | | | | | | |
Proceeds from sale of Units, net of underwriting discounts paid
|
| | | | — | | | | | | 269,500,000 | | |
Proceeds from sale of Private Placement Warrants
|
| | | | — | | | | | | 7,500,000 | | |
Proceeds from promissory notes – related party
|
| | | | — | | | | | | 231,366 | | |
Repayment of promissory notes – related party
|
| | | | — | | | | | | (231,366) | | |
Payment of offering costs
|
| | | | — | | | | | | (437,880) | | |
Net cash provided by financing activities
|
| | | | — | | | | | | 276,562,120 | | |
Net Change in Cash
|
| | | | (459,540) | | | | | | 1,305,608 | | |
Cash – Beginning
|
| | | | 1,305,608 | | | | | | — | | |
Cash – Ending | | | | $ | 846,068 | | | | | $ | 1,305,608 | | |
Supplemental cash flow information: | | | | | | | | | | | | | |
Cash paid for income taxes
|
| | | $ | 213,233 | | | | | $ | — | | |
Non-cash investing and financing activities: | | | | | | | | | | | | | |
Initial classification of Class A common stock subject to redemption
|
| | | $ | — | | | | | $ | 243,609,820 | | |
Change in value of Class A common stock subject to possible
redemption |
| | | $ | (20,522,284) | | | | | $ | 2,969,403 | | |
Initial classification of warrant liabilities
|
| | | $ | — | | | | | | 18,300,000 | | |
Deferred underwriting fee payable
|
| | | $ | — | | | | | $ | 9,625,000 | | |
Offering costs paid directly by Sponsor in exchange for the issuance of Class B common stock to Sponsor
|
| | | $ | — | | | | | $ | 25,000 | | |
Balance Sheet as of September 17, 2019
|
| |
As Reported
|
| |
Period
Adjustment |
| |
As Adjusted
|
| |||||||||
Warrant Liability
|
| | | $ | — | | | | | $ | 18,300,000 | | | | | $ | 18,300,000 | | |
Class A common stock subject to possible redemption
|
| | | | 261,909,820 | | | | | | (18,300,000) | | | | | | 243,609,820 | | |
Class A common stock
|
| | | | 131 | | | | | | 183 | | | | | | 314 | | |
Additional paid-in capital
|
| | | $ | 5,000,481 | | | | | $ | 636,486 | | | | | $ | 5,636,967 | | |
Accumulated deficit
|
| | | $ | (1,297) | | | | | $ | (636,669) | | | | | $ | (637,966) | | |
Total Stockholders’ Equity
|
| | | $ | 5,000,003 | | | | | $ | 0 | | | | | $ | 5,000,003 | | |
Number of shares subject to possible redemption
|
| | | | 26,190,982 | | | | | | (1,830,000) | | | | | | 24,360,982 | | |
Balance Sheet as of September 30, 2019
|
| | | | | | | | | | | | | | | | | | |
Warrant Liability
|
| | | $ | — | | | | | $ | 17,966,667 | | | | | $ | 17,966,667 | | |
Class A common stock subject to possible redemption
|
| | | | 262,009,255 | | | | | | (17,966,667) | | | | | | 244,042,588 | | |
Class A common stock
|
| | | | 131 | | | | | | 180 | | | | | | 311 | | |
Additional paid-in capital
|
| | | $ | 4,901,046 | | | | | $ | 303,156 | | | | | $ | 5,204,202 | | |
Retained earnings (Accumulated deficit)
|
| | | | 98,139 | | | | | | (303,336) | | | | | | (205,197) | | |
Total Stockholders’ Equity
|
| | | $ | 5,000,004 | | | | | $ | — | | | | | $ | 5,000,004 | | |
Number of shares subject to possible redemption
|
| | | | 26,187,385 | | | | | | (1,795,738) | | | | | | 24,391,647 | | |
Balance Sheet as of December 31, 2019
|
| | | | | | | | | | | | | | | | | | |
Warrant Liability
|
| | | $ | — | | | | | $ | 16,116,667 | | | | | $ | 16,116,667 | | |
Class A common stock subject to possible redemption
|
| | | | 262,695,890 | | | | | | (16,116,667) | | | | | | 246,579,223 | | |
Class A common stock
|
| | | | 132 | | | | | | 161 | | | | | | 293 | | |
Additional paid-in capital
|
| | | $ | 4,214,410 | | | | | $ | (1,546,825) | | | | | $ | 2,667,585 | | |
Retained earnings
|
| | | $ | 784,778 | | | | | $ | 1,546,664 | | | | | $ | 2,331,442 | | |
Total Stockholders’ Equity
|
| | | $ | 5,000,008 | | | | | $ | — | | | | | $ | 5,000,008 | | |
Number of shares subject to possible redemption
|
| | | | 26,180,927 | | | | | | (1,606,227) | | | | | | 24,574,700 | | |
Statement of Operations for the period from May 24, 2019 (Inception) through
September 30, 2019 |
| | | | | | | | | | | | | | | | | | |
Transaction costs allocable to warrant liabilities
|
| | | | — | | | | | | (636,669) | | | | | | (636,669) | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | 333,333 | | | | | | 333,333 | | |
Net income (loss)
|
| | | $ | 98,139 | | | | | $ | (303,336) | | | | | $ | (205,197) | | |
Basic and diluted weighted average shares outstanding, common stock
|
| | | | 6,444,901 | | | | | | — | | | | | | 6,444,901 | | |
Basic and diluted net loss per common share, common stock
|
| | | $ | 0.01 | | | | | $ | (0.05) | | | | | $ | (0.05) | | |
Statement of Operations for the year ended December 31, 2019
|
| | | | | | | | | | | | | | | | | | |
Transaction costs allocable to warrant liabilities
|
| | | | — | | | | | | (636,669) | | | | | | (636,669) | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | 2,218,333 | | | | | | 2,218,333 | | |
Net income
|
| | | $ | 784,778 | | | | | $ | 1,546,664 | | | | | $ | 2,331,442 | | |
Basic and diluted weighted average shares outstanding, common stock
|
| | | | 7,170,375 | | | | | | 855,194 | | | | | | 8,025,569 | | |
Basic and diluted net income (loss) per common share, common stock
|
| | | $ | (0.01) | | | | | $ | 0.20 | | | | | $ | 0.19 | | |
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemptio
|
| | | | 26,187,830 | | | | | | (1,799,980) | | | | | | 24,387,850 | | |
Balance Sheet as of March 31, 2020
|
| |
As Reported
|
| |
Period
Adjustment |
| |
As Restated
|
| |||||||||
Warrant Liability
|
| | | $ | — | | | | | $ | 10,991,667 | | | | | $ | 10,991,667 | | |
Class A common stock subject to possible redemption
|
| | | | 263,267,961 | | | | | | (10,991,667) | | | | | | 252,276,294 | | |
Class A common stock
|
| | | | 134 | | | | | | 110 | | | | | | 244 | | |
Additional paid-in capital
|
| | | $ | 3,642,337 | | | | | $ | (6,671,774) | | | | | $ | (3,029,437) | | |
Retained earnings
|
| | | $ | 1,356,849 | | | | | $ | 6,671,664 | | | | | $ | 8,028,513 | | |
Total Stockholders’ Equity
|
| | | $ | 5,000,008 | | | | | $ | — | | | | | $ | 5,000,008 | | |
Number of shares subject to possible redemption
|
| | | | 26,163,140 | | | | | | (1,092,334) | | | | | | 25,070,806 | | |
Balance Sheet as of June 30, 2020
|
| | | | | | | | | | | | | | | | | | |
Warrant Liability
|
| | | $ | — | | | | | $ | 13,500,000 | | | | | $ | 13,500,000 | | |
Class A common stock subject to possible redemption
|
| | | | 263,261,986 | | | | | | (13,500,000) | | | | | | 249,761,986 | | |
Class A common stock
|
| | | | 134 | | | | | | 135 | | | | | | 269 | | |
Additional paid-in capital
|
| | | $ | 3,648,312 | | | | | $ | (4,163,466) | | | | | $ | (515,154) | | |
Retained earnings
|
| | | $ | 1,350,867 | | | | | $ | 4,163,331 | | | | | $ | 5,514,198 | | |
Total Stockholders’ Equity
|
| | | $ | 5,000,001 | | | | | $ | — | | | | | $ | 5,000,001 | | |
Number of shares subject to possible redemption
|
| | | | 26,156,915 | | | | | | (1,341,319) | | | | | | 24,815,596 | | |
Balance Sheet as of September 30, 2020
|
| | | | | | | | | | | | | | | | | | |
Warrant Liability
|
| | | $ | — | | | | | $ | 18,525,000 | | | | | $ | 18,525,000 | | |
Class A common stock subject to possible redemption
|
| | | | 263,161,825 | | | | | | (18,525,000) | | | | | | 244,636,825 | | |
Class A common stock
|
| | | | 136 | | | | | | 185 | | | | | | 321 | | |
Additional paid-in capital
|
| | | $ | 3,748,471 | | | | | $ | 861,484 | | | | | $ | 4,609,955 | | |
Retained earnings
|
| | | $ | 1,250,712 | | | | | $ | (861,669) | | | | | $ | 389,043 | | |
Total Stockholders’ Equity
|
| | | $ | 5,000,007 | | | | | $ | — | | | | | $ | 5,000,007 | | |
Number of shares subject to possible redemption
|
| | | | 26,141,235 | | | | | | (1,840,185) | | | | | | 24,301,050 | | |
Balance Sheet as of December 31, 2020
|
| | | | | | | | | | | | | | | | | | |
Warrant Liability
|
| | | $ | — | | | | | $ | 36,766,667 | | | | | $ | 36,766,667 | | |
Class A common stock subject to possible redemption
|
| | | | 262,823,607 | | | | | | (36,766,668) | | | | | | 226,056,939 | | |
Class A common stock
|
| | | | 136 | | | | | | 366 | | | | | | 502 | | |
Additional paid-in capital
|
| | | $ | 4,086,689 | | | | | $ | 19,102,971 | | | | | $ | 23,189,660 | | |
Retained earnings (Accumulated deficit)
|
| | | $ | 912,496 | | | | | $ | (19,103,336) | | | | | $ | (18,190,840) | | |
Total Stockholders’ Equity
|
| | | $ | 5,000,009 | | | | | $ | 1 | | | | | $ | 5,000,010 | | |
Number of shares subject to possible redemption
|
| | | | 26,136,620 | | | | | | (3,656,279) | | | | | | 22,480,341 | | |
Statement of Operations for the period ended March 31, 2020
|
| | | | | | | | | | | | | | | | | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | 5,125,000 | | | | | | 5,125,000 | | |
Net income
|
| | | $ | 572,071 | | | | | $ | 5,125,000 | | | | | $ | 5,697,071 | | |
Basic and diluted weighted average shares outstanding, common stock
|
| | | | 8,194,073 | | | | | | — | | | | | | 8,194,073 | | |
Basic and diluted net income per common share, common stock
|
| | | $ | — | | | | | $ | 0.63 | | | | | $ | 0.63 | | |
Statement of Operations for the period ended June 30, 2020
|
| | | | | | | | | | | | | | | | | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | 2,616,667 | | | | | | 2,616,667 | | |
Net income
|
| | | $ | 566,089 | | | | | $ | 2,616,667 | | | | | $ | 3,182,756 | | |
Basic and diluted weighted average shares outstanding, common stock
|
| | | | 8,202,967 | | | | | | — | | | | | | 8,202,967 | | |
Basic and diluted net income (loss) per common share, common stock
|
| | | $ | (0.02) | | | | | $ | 0.32 | | | | | $ | 0.30 | | |
Statement of Operations for the period ended September 30, 2020
|
| | | | | | | | | | | | | | | | | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | (2,408,333) | | | | | | (2,408,333) | | |
Net income (loss)
|
| | | $ | 465,934 | | | | | $ | (2,408,333) | | | | | $ | (1,942,399) | | |
Basic and diluted weighted average shares outstanding, common
stock |
| | | | 8,208,043 | | | | | | — | | | | | | 8,208,043 | | |
Basic and diluted net loss per common share, common stock
|
| | | $ | (0.03) | | | | | $ | (0.29) | | | | | $ | (0.32) | | |
Statement of Operations for the year ended December 31, 2020
|
| | | | | | | | | | | | | | | | | | |
Change in fair value of warrant liabilities
|
| | | | — | | | | | | (20,650,000) | | | | | | (20,650,000) | | |
Net income (loss)
|
| | | $ | 127,718 | | | | | $ | (20,650,000) | | | | | $ | (20,522,282) | | |
Basic and diluted weighted average shares outstanding, common stock
|
| | | | 8,214,508 | | | | | | 1,470,676 | | | | | | 9,685,184 | | |
Basic and diluted net loss per common share, common
stock |
| | | $ | (0.05) | | | | | $ | (2.12) | | | | | $ | (2.17) | | |
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption
|
| | | | 26,160,492 | | | | | | (1,470,676) | | | | | | 24,689,816 | | |
| | |
Year Ended
December 31, |
| |
For the Period
from May 24, 2019 (inception) through December 31, |
| ||||||
| | |
2020
|
| |
2019
|
| ||||||
Common stock subject to possible redemption | | | | | | | | | | | | | |
Numerator: Earnings allocable to Common stock subject to possible redemption
|
| | | | | | | | | | | | |
Interest earned on marketable securities held in Trust Account
|
| | | $ | 492,250 | | | | | $ | 832,225 | | |
Unrealized loss on marketable securities held in Trust Account
|
| | | | — | | | | | | — | | |
Net Income allocable to shares subject to possible redemption
|
| | | $ | 492,250 | | | | | $ | 832,225 | | |
Denominator: Weighted Average Common stock subject to possible redemption
|
| | | | | | | | | | | | |
Basic and diluted weighted average shares outstanding
|
| | | | 24,689,816 | | | | | | 24,387,850 | | |
Basic and diluted net income per share
|
| | | $ | 0.02 | | | | | $ | 0.03 | | |
Non-Redeemable Common Stock | | | | | | | | | | | | | |
Numerator: Net Loss minus Net Earnings | | | | | | | | | | | | | |
Net Income (Loss)
|
| | | $ | (20,522,282) | | | | | $ | 2,331,442 | | |
Net Income (Loss) allocable to Common stock subject to possible redemption
|
| | | | (492,250) | | | | | | (832,225) | | |
Non-Redeemable Net Loss
|
| | | $ | (21,014,532) | | | | | $ | 1,499,217 | | |
Denominator: Weighted Average Non-Redeemable Common Stock | | | | | | | | | | | | | |
Basic and diluted weighted average shares outstanding
|
| | | | 9,685,184 | | | | | | 8,025,569 | | |
Basic and diluted net income (loss) per share
|
| | | $ | (2.17) | | | | | $ | 0.19 | | |
| | |
As of December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Deferred tax asset | | | | | | | | | | | | | |
Organizational costs/Startup expenses
|
| | | $ | 122,876 | | | | | $ | — | | |
Total deferred tax asset
|
| | | | 122,876 | | | | | | — | | |
Valuation allowance
|
| | | | (122,876) | | | | | | — | | |
Deferred tax asset, net of allowance
|
| | | $ | — | | | | | $ | — | | |
| | |
As of December 31,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Federal | | | | | | | | | | | | | |
Current
|
| | | $ | 170,647 | | | | | $ | 208,612 | | |
Deferred
|
| | | | (99,629) | | | | | | — | | |
State and Local | | | | | | | | | | | | | |
Current
|
| | | | 39,818 | | | | | | — | | |
Deferred
|
| | | | (23,247) | | | | | | — | | |
Change in valuation allowance
|
| | | | 122,876 | | | | | | — | | |
Income tax provision
|
| | | $ | 210,465 | | | | | $ | 208,612 | | |
| | |
December 31,
2020 |
| |
December 31,
2019 |
| ||||||
Statutory federal income tax rate
|
| | | | 21.0% | | | | | | 21.0% | | |
State taxes, net of federal tax benefit
|
| | | | 4.9% | | | | | | 0.0% | | |
Transaction costs allocable to warrant liabilities
|
| | | | 0.0% | | | | | | 5.3% | | |
Change in FV of warrant liabilities
|
| | | | (26.3)% | | | | | | (18.1)% | | |
Valuation allowance
|
| | | | (0.6)% | | | | | | 0.0% | | |
Income tax provision
|
| | | | (1.0)% | | | | | | 21.0% | | |
Description
|
| |
Level
|
| |
December 31,
2020 |
| |
December 31,
2019 |
| |||||||||
Assets: | | | | | | | | | | | | | | | | | | | |
Marketable securities held in Trust Account
|
| | | | 1 | | | | | $ | 276,943,339 | | | | | $ | 276,261,596 | | |
Liabilities: | | | | | | | | | | | | | | | | | | | |
Warrant Liability — Public Warrants
|
| | | | 1 | | | | | | 22,366,667 | | | | | | 9,716,667 | | |
Warrant Liability — Private Placement Warrants
|
| | | | 3 | | | | | | 14,400,000 | | | | | | 6,400,000 | | |
Input
|
| |
September 19,
2019 (Initial Measurement) |
| |||
Risk-free interest rate
|
| | | | 1.7% | | |
Expected term (years)
|
| | | | 1.5 | | |
Expected volatility
|
| | | | 40.0% | | |
Exercise price
|
| | | $ | 11.60 | | |
Fair value of Units
|
| | | $ | 7.66 | | |
| | |
Private
Placement |
| |
Public
|
| |
Warrant
Liabilities |
| |||||||||
Fair value –
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
Initial measurement on September 17, 2019 (IPO)
|
| | | | 7,300,000 | | | | | | 11,000,000 | | | | | | 18,300,000 | | |
Change in valuation inputs or other assumptions
|
| | | | (900,000) | | | | | | (1,283,333) | | | | | | (2,183,333) | | |
Fair value as of December 31, 2019
|
| | | $ | 6,400,000 | | | | | $ | 9,716,667 | | | | | $ | 16,116,667 | | |
Change in valuation inputs or other assumptions
|
| | | | 8,000,000 | | | | | | 12,650,000 | | | | | | 20,650,000 | | |
Fair value as of December 31, 2020
|
| | | $ | 14,400,000 | | | | | $ | 22,366,667 | | | | | $ | 36,766,667 | | |
| | |
As of
March 31, 2021 |
| |
As of
December 31, 2020 |
| ||||||
| | |
(unaudited)
|
| | | | | | | |||
Assets | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash
|
| | | $ | 485,220 | | | | | $ | 846,068 | | |
Prepaid expenses
|
| | | | 123,500 | | | | | | 50,000 | | |
Total current assets
|
| | | | 608,720 | | | | | | 896,068 | | |
Deferred offering costs
|
| | | | 1,200,000 | | | | | | — | | |
Marketable securities held in Trust Account
|
| | | | 276,947,475 | | | | | | 276,943,339 | | |
Total assets
|
| | | $ | 278,756,195 | | | | | $ | 277,839,407 | | |
Liabilities, Temporary Equity, and Stockholders’ Equity | | | | | | | | | | | | | |
Liabilities | | | | | | | | | | | | | |
Current liabilities:
|
| | | | | | | | | | | | |
Accounts payable and accrued liabilities
|
| | | $ | 1,306,711 | | | | | $ | 158,947 | | |
Accrued offering costs
|
| | | | 26,000 | | | | | | 26,000 | | |
Income taxes payable
|
| | | | 205,844 | | | | | | 205,844 | | |
Total current liabilities
|
| | | | 1,538,555 | | | | | | 390,791 | | |
Deferred underwriting fee payable
|
| | | | 9,625,000 | | | | | | 9,625,000 | | |
Warrant liabilities
|
| | | | 37,616,668 | | | | | | 36,766,667 | | |
Total liabilities
|
| | | | 48,780,223 | | | | | | 46,782,458 | | |
Commitments and contingencies (Note 6) | | | | | | | | | | | | | |
Temporary Equity | | | | | | | | | | | | | |
Class A common stock subject to possible redemption 22,339,729 and 22,480,341 shares at redemption value as of March 31, 2021 and December 31, 2020, respectively
|
| | | | 224,975,969 | | | | | | 226,056,939 | | |
Stockholders’ Equity | | | | | | | | | | | | | |
Preferred Stock, $0.0001 par value, 1,000,000 shares authorized, none issued and outstanding
|
| | | | — | | | | | | — | | |
Class A Common stock, $0.0001 par value, 100,000,000 shares authorized, 5,160,271 and 5,019,659 shares issued and outstanding (excluding 22,339,729 and 22,480,341 shares subject to possible redemption) as of March 31, 2021 and December 31, 2020, respectively
|
| | | | 516 | | | | | | 502 | | |
Class B Common stock, $0.0001 par value, 10,000,000 shares authorized,
6,875,000 shares issued and outstanding as of March 31, 2021 and December 31, 2020 |
| | | | 688 | | | | | | 688 | | |
Additional paid-in capital
|
| | | | 24,270,617 | | | | | | 23,189,660 | | |
Accumulated deficit
|
| | | | (19,271,818) | | | | | | (18,190,840) | | |
Total stockholders’ equity
|
| | | | 5,000,003 | | | | | | 5,000,010 | | |
Total liabilities, temporary equity, and stockholders’ equity
|
| | | $ | 278,756,195 | | | | | $ | 277,839,407 | | |
| | |
For the Three Months
Ended March 31, |
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Operating costs
|
| | | | 235,113 | | | | | | 145,130 | | |
Loss from operations
|
| | | | (235,113) | | | | | | (145,130) | | |
Other income (expense) | | | | | | | | | | | | | |
Interest income on marketable securities held in Trust Account
|
| | | | 4,136 | | | | | | 869,270 | | |
Change in fair value of warrant liablities
|
| | | | (850,001) | | | | | | 5,125,000 | | |
Total other income (expense)
|
| | | | (845,865) | | | | | | 5,994,270 | | |
(Loss) income before provision for income taxes
|
| | | | (1,080,978) | | | | | | 5,849,140 | | |
Provision for income taxes
|
| | | | — | | | | | | (152,069) | | |
Net (loss) income
|
| | | $ | (1,080,978) | | | | | $ | 5,697,071 | | |
Basic and diluted weighted average shares outstanding, common stock subject to
possible redemption |
| | |
|
22,480,341
|
| | | |
|
25,070,806
|
| |
Basic and diluted net income per share, common stock subject to possible redemption
|
| | |
|
—
|
| | | |
|
0.02
|
| |
Weighted average shares outstanding, basic and diluted, common stock
|
| | | | 11,894,659 | | | | | | 8,194,073 | | |
Net loss (income) per share - basic and diluted, common stock
|
| | | $ | (0.09) | | | | | $ | 0.62 | | |
| | |
Class A
Common Stock |
| |
Class B
Common Stock |
| |
Additional
Paid-in capital |
| |
Retained
Earnings (Accumulated Deficit) |
| |
Total
|
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||
Balance as of January 1, 2021
|
| | | | 5,019,659 | | | | |
$
|
502
|
| | | | | 6,875,000 | | | | |
$
|
688
|
| | | | $ | 23,189,660 | | | | | $ | (18,190,840) | | | | | $ | 5,000,010 | | |
Change in common stock subject to redemption
|
| | | | 140,612 | | | | | | 14 | | | | | | — | | | | | | — | | | | | | 1,080,957 | | | | | | — | | | | | | 1,080,971 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,080,978) | | | | | | (1,080,978) | | |
Balance as of March 31, 2021
|
| | | | 5,160,271 | | | | | $ | 516 | | | | | | 6,875,000 | | | | | $ | 688 | | | | | $ | 24,270,617 | | | | | $ | (19,271,818) | | | | | $ | 5,000,003 | | |
Balance as of January 1, 2020
|
| | | | 2,925,300 | | | | | $ | 293 | | | | | | 6,875,000 | | | | | $ | 688 | | | | | $ | 2,667,585 | | | | | $ | 2,331,442 | | | | | $ | 5,000,008 | | |
Change in common stock subject to redemption
|
| | | | (496,106) | | | | | | (50) | | | | | | — | | | | | | — | | | | | | (5,697,021) | | | | | | — | | | | | | (5,697,071) | | |
Net income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 5,697,071 | | | | | | 5,697,071 | | |
Balance as of March 31, 2020
|
| | | | 2,429,194 | | | | | $ | 243 | | | | | | 6,875,000 | | | | | $ | 688 | | | | | $ | (3,029,436) | | | | | $ | 8,028,513 | | | | | $ | 5,000,008 | | |
| | |
For the Three Months
Ended March 31, |
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Cash Flows From Operating Activities: | | | | | | | | | | | | | |
Net (loss) income
|
| | | $ | (1,080,978) | | | | | $ | 5,697,071 | | |
Adjustments to reconcile net (loss) income to cash used in operating activities:
|
| | | | | | | | | | | | |
Interest earned on Trust Account
|
| | | | (4,136) | | | | | | (869,270) | | |
Change in fair value of warrant liabilities
|
| | | | 850,001 | | | | | | (5,125,000) | | |
Change in operating assets and liabilities:
|
| | | | | | | | | | | | |
Prepaid expenses
|
| | | | (73,500) | | | | | | (23,625) | | |
Accounts payable and accrued expenses
|
| | | | (52,236) | | | | | | (43,518) | | |
Income taxes payable
|
| | | | — | | | | | | 152,069 | | |
Net cash used in operating activities
|
| | | | (360,848) | | | | | | (212,273) | | |
Net decrease in cash
|
| | | | (360,848) | | | | | | (212,273) | | |
Cash – beginning of period
|
| | | | 846,068 | | | | | | 1,305,608 | | |
Cash – end of period
|
| | | $ | 485,220 | | | | | $ | 1,093,335 | | |
Supplemental non-cash financing activities: | | | | | | | | | | | | | |
Deferred offering costs
|
| | | | (1,200,000) | | | | | | — | | |
Change in common stock subject to redemption
|
| | | $ | (1,080,971) | | | | | $ | 5,697,071 | | |
| | |
For the Three Months
Ended March 31, |
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Common stock subject to possible redemption | | | | | | | | | | | | | |
Numerator: Earnings allocable to Common stock subject to possible redemption
|
| | | | | | | | | | | | |
Interest earned on marketable securities held in Trust Account
|
| | | $ | — | | | | | $ | 634,775 | | |
Unrealized loss on marketable securities held in Trust Account
|
| | | | — | | | | | | — | | |
Net Income allocable to shares subject to possible redemption
|
| | | $ | — | | | | | $ | 634,775 | | |
Denominator: Weighted Average Common stock subject to possible redemption
|
| | | | | | | | | | | | |
Basic and diluted weighted average shares outstanding
|
| | | | 22,480,341 | | | | | | 25,070,806 | | |
Basic and diluted net income per share
|
| | | $ | — | | | | | $ | 0.02 | | |
Non-Redeemable Common Stock | | | | | | | | | | | | | |
Numerator: Net Loss minus Net Earnings | | | | | | | | | | | | | |
Net Income (loss)
|
| | | $ | (1,080,978) | | | | | $ | 5,697,071 | | |
Net Income allocable to Common stock subject to possible redemption
|
| | | | — | | | | | | (634,775) | | |
Non-Redeemable Net Loss
|
| | | $ | (1,080,978) | | | | | $ | 5,062,296 | | |
Denominator: Weighted Average Non-Redeemable Common Stock | | | | | | | | | | | | | |
Basic and diluted weighted average shares outstanding
|
| | | | 11,894,659 | | | | | | 8,194,073 | | |
Basic and diluted net income (loss) per share
|
| | | $ | (0.09) | | | | | $ | 0.62 | | |
| | | | Level 1: | | | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
| | | | Level 2: | | | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
| | | | Level 3: | | | Unobservable inputs based on management’s assessment of the assumptions that market participants would use in pricing the asset or liability. | |
Description
|
| |
Level
|
| |
March 31,
2021 |
| |
December 31,
2020 |
| |||||||||
Assets: | | | | | | | | | | | | | | | | | | | |
Marketable securities held in Trust Account
|
| | | | 1 | | | | | $ | 276,947,475 | | | | | $ | 276,943,339 | | |
Liabilities: | | | | | | | | | | | | | | | | | | | |
Warrant Liability — Public Warrants
|
| | | | 1 | | | | | | 22,916,668 | | | | | | 22,366,667 | | |
Warrant Liability — Private Placement Warrants
|
| | | | 3 | | | | | | 14,700,000 | | | | | | 14,400,000 | | |
| | |
Private
Placement |
| |
Public
|
| |
Warrant
Liabilities |
| |||||||||
Fair value as of Janaury 1, 2021
|
| | | $ | 14,400,000 | | | | | $ | 22,366,667 | | | | | $ | 36,766,667 | | |
Change in fair value of warrant liabilities
|
| | | | 300,000 | | | | | | 550,001 | | | | | | 850,001 | | |
Fair value as of March 31, 2021
|
| | | $ | 14,700,000 | | | | | $ | 22,916,668 | | | | | $ | 37,616,668 | | |
Input
|
| |
March 31, 2021
|
| |
December 31, 2020
|
| ||||||
Risk-free interest rate
|
| | | | 0.96% | | | | | | 0.42% | | |
Risky Drift
|
| | | | 5% | | | | | | 5% | | |
Expected term (years)
|
| | | | 5 | | | | | | 5 | | |
Expected volatility
|
| | | | 40.0% | | | | | | 40.0% | | |
Exercise price
|
| | | $ | 11.50 | | | | | $ | 11.50 | | |
| | |
As of September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Assets | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 12,162 | | | | | $ | 22,177 | | |
Restricted cash
|
| | | | 114 | | | | | | 114 | | |
Prepaid expenses and other current assets
|
| | | | 1,011 | | | | | | 665 | | |
Accounts receivable
|
| | | | 1,092 | | | | | | 501 | | |
Total current assets
|
| | | | 14,379 | | | | | | 23,457 | | |
Non-current assets | | | | | | | | | | | | | |
Investment in joint venture
|
| | | | 200 | | | | | | 200 | | |
Other non-current assets
|
| | | | 107 | | | | | | 124 | | |
Intangible assets, net
|
| | | | 533 | | | | | | 723 | | |
Operating right-of-use asset
|
| | | | 737 | | | | | | 397 | | |
Property and equipment, net
|
| | | | 1,759 | | | | | | 1,718 | | |
Total assets
|
| | | $ | 17,715 | | | | | $ | 26,619 | | |
Liabilities and Stockholders’ Equity | | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | | |
Accounts payable and accrued expenses
|
| | | $ | 776 | | | | | $ | 2,186 | | |
Deferred revenue
|
| | | | 3,973 | | | | | | 3,328 | | |
Operating lease liability, current
|
| | | | 430 | | | | | | 195 | | |
Note payable
|
| | | | 1,165 | | | | | | — | | |
Total current liabilities
|
| | | | 6,344 | | | | | | 5,709 | | |
Non-current liabilities | | | | | | | | | | | | | |
Operating lease liability, long-term
|
| | | | 291 | | | | | | 175 | | |
Total liabilities
|
| | | | 6,635 | | | | | | 5,884 | | |
Commitments and Contingencies (Note 12) | | | | | | | | | | | | | |
Stockholders’ Equity | | | | | | | | | | | | | |
Preferred stock – Series Seed, $0.00001 par value, 2,817,000 shares authorized, issued and outstanding at September 30, 2020 and 2019
|
| | | | — | | | | | | — | | |
Preferred stock – Series A, $0.00001 par value, 6,734,526 shares authorized, 6,734,517 issued and outstanding at September 30, 2020 and 2019
|
| | | | — | | | | | | — | | |
Preferred stock – Series B, $0.00001 par value, 12,660,000 shares authorized at September 30, 2020 and 2019, 12,565,294 shares issued and outstanding at September 30, 2020 and 2019
|
| | | | — | | | | | | — | | |
Common stock, $0.00001 par value; 50,300,000 authorized; 12,592,851 and 12,502,885 shares issued and outstanding at September 30, 2020 and 2019, respectively.
|
| | | | — | | | | | | — | | |
Additional paid in capital
|
| | | | 48,218 | | | | | | 47,713 | | |
Accumulated deficit
|
| | | | (37,138) | | | | | | (26,978) | | |
Total stockholders’ equity
|
| | | | 11,080 | | | | | | 20,735 | | |
Total Liabilities and Stockholders’ Equity
|
| | | $ | 17,715 | | | | | $ | 26,619 | | |
| | |
For the Years Ended September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Revenue
|
| | | $ | 23,434 | | | | | $ | 31,196 | | |
Operating expenses | | | | | | | | | | | | | |
Cost of revenue
|
| | | | 21,107 | | | | | | 26,497 | | |
Software development
|
| | | | 861 | | | | | | 751 | | |
General and administrative
|
| | | | 9,292 | | | | | | 10,476 | | |
Selling and marketing
|
| | | | 2,533 | | | | | | 5,013 | | |
Total operating expenses
|
| | | | 33,793 | | | | | | 42,737 | | |
Loss from operations
|
| | | | (10,359) | | | | | | (11,541) | | |
Other non-operating income (expense) | | | | | | | | | | | | | |
Interest income
|
| | | | 200 | | | | | | 718 | | |
Interest expense
|
| | | | (1) | | | | | | (15) | | |
Total other income
|
| | | | 199 | | | | | | 703 | | |
Net loss
|
| | | $ | (10,160) | | | | | $ | (10,838) | | |
Weighted average shares outstanding, basic and diluted
|
| | | | 12,512,567 | | | | | | 12,409,010 | | |
Net loss per share, basic and diluted
|
| | | $ | (0.81) | | | | | $ | (0.87) | | |
| | |
Preferred Stock —
Series Seed |
| |
Preferred Stock —
Series A |
| |
Preferred Stock —
Series B |
| |
Common Stock
|
| |
Additional
Paid- In Capital |
| |
Accumulated
Deficit |
| |
Treasury
Stock |
| |
Total
Stockholders’ Equity |
| ||||||||||||||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
Balance at October 1, 2018
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 16,623,396 | | | | | $ | — | | | | | $ | 48,964 | | | | | $ | (16,140) | | | | | $ | (1,684) | | | | | $ | 31,140 | | |
Cancellation of Treasury stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,432,748) | | | | | | — | | | | | | (1,684) | | | | | | — | | | | | | 1,684 | | | | | | — | | |
Stock option exercises
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 312,237 | | | | | | — | | | | | | 116 | | | | | | — | | | | | | — | | | | | | 116 | | |
Stock-based compensation
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 317 | | | | | | — | | | | | | — | | | | | | 317 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (10,838) | | | | | | — | | | | | | (10,838) | | |
Balance at September 30, 2019
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 12,502,885 | | | | | $ | — | | | | | $ | 47,713 | | | | | $ | (26,978) | | | | | $ | — | | | | | $ | 20,735 | | |
Stock option exercises
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 89,966 | | | | | | — | | | | | | 15 | | | | | | — | | | | | | — | | | | | | 15 | | |
Stock-based compensation
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 490 | | | | | | — | | | | | | — | | | | | | 490 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (10,160) | | | | | | — | | | | | | (10,160) | | |
Balance at September 30, 2020
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 12,592,851 | | | | | $ | — | | | | | $ | 48,218 | | | | | $ | (37,138) | | | | | $ | — | | | | | $ | 11,080 | | |
| | |
For the Years Ended September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Cash Flows From Operating Activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (10,160) | | | | | $ | (10,838) | | |
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities:
|
| | | | | | | | | | | | |
Depreciation and amortization
|
| | | | 526 | | | | | | 472 | | |
Stock-based compensation
|
| | | | 490 | | | | | | 317 | | |
Loss on sale of property and equipment
|
| | | | — | | | | | | 28 | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Prepaid expenses and other current assets
|
| | | | (346) | | | | | | (315) | | |
Accounts receivable
|
| | | | (591) | | | | | | (165) | | |
Other non-current assets
|
| | | | 17 | | | | | | (93) | | |
Operating lease assets/liabilities
|
| | | | 11 | | | | | | (27) | | |
Accounts payable and accrued expenses
|
| | | | (1,410) | | | | | | (402) | | |
Deferred revenue
|
| | | | 645 | | | | | | 721 | | |
Net cash used in operating activities
|
| | | | (10,818) | | | | | | (10,302) | | |
Cash Flows From Investing Activities: | | | | | | | | | | | | | |
Purchase of customer list
|
| | | | — | | | | | | (250) | | |
Investment in joint venture
|
| | | | — | | | | | | (200) | | |
Purchase of property and equipment
|
| | | | (377) | | | | | | (604) | | |
Net cash used in investing activities
|
| | | | (377) | | | | | | (1,054) | | |
Cash Flows From Financing Activities: | | | | | | | | | | | | | |
Proceeds from the exercise of common stock options
|
| | | | 15 | | | | | | 116 | | |
Proceeds from note payable
|
| | | | 1,165 | | | | | | — | | |
Net cash provided by financing activities
|
| | | | 1,180 | | | | | | 116 | | |
Net decrease in cash and cash equivalents and restricted cash
|
| | | | (10,015) | | | | | | (11,240) | | |
Cash and cash equivalents and restricted cash – beginning
|
| | | | 22,291 | | | | | | 33,531 | | |
Cash and cash equivalents and restricted cash – ending
|
| | | $ | 12,276 | | | | | $ | 22,291 | | |
Cash and cash equivalents
|
| | | $ | 12,162 | | | | | $ | 22,177 | | |
Restricted cash
|
| | | | 114 | | | | | | 114 | | |
Total
|
| | | $ | 12,276 | | | | | $ | 22,291 | | |
Supplemental cash flow information | | | | | | | | | | | | | |
Cash paid for:
|
| | | | | | | | | | | | |
Interest
|
| | | $ | — | | | | | $ | — | | |
Income Taxes
|
| | | $ | — | | | | | $ | — | | |
Supplemental non-cash investing and financing activities | | | | | | | | | | | | | |
Right of use assets acquired under operating leases
|
| | | $ | 788 | | | | | $ | 512 | | |
| | |
Quoted Prices in Active
Markets for Identical Assets/Liabilities (Level 1) |
| |
Quoted Prices for Similar
Assets or Liabilities in Active Markets (Level 2) |
| |
Significant
Unobservable Inputs (Level 3) |
| |||||||||
September 30, 2019 | | | | | | | | | | | | | | | | | | | |
Commission liability
|
| | | $ | — | | | | | $ | — | | | | | $ | 73 | | |
| | |
Commission Liability
Roll Forward |
| |||
As of September 30, 2018
|
| | | $ | 527 | | |
Payments
|
| | | | (469) | | |
Accretion
|
| | | | 15 | | |
As of September 30, 2019
|
| | | $ | 73 | | |
Payments
|
| | | | (74) | | |
Accretion
|
| | | | 1 | | |
As of September 30, 2020
|
| | | $ | — | | |
| | |
Year Ended
September 30, |
| |||||||||
Product Line
|
| |
2020
|
| |
2019
|
| ||||||
Short distance flight services
|
| | | $ | 9,941 | | | | | $ | 26,017 | | |
MediMobility organ transplant and jet
|
| | | | 12,785 | | | | | | 4,965 | | |
Other
|
| | | | 708 | | | | | | 214 | | |
Total Revenue
|
| | | $ | 23,434 | | | | | $ | 31,196 | | |
| | |
Useful Life
(in years) |
| |
As of September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| |||||||||
Furniture and fixtures
|
| |
5
|
| | | $ | 437 | | | | | $ | 383 | | |
Technology equipment
|
| |
3
|
| | | | 182 | | | | | | 174 | | |
Leasehold improvements
|
| |
Shorter of useful
life or life of lease |
| | | | 2,215 | | | | | | 1,900 | | |
Vehicle
|
| |
5
|
| | | | 5 | | | | | | 5 | | |
Total property and equipment, gross
|
| | | | | | | 2,839 | | | | | | 2,462 | | |
Less: Accumulated depreciation and amortization
|
| | | | | | | (1,080) | | | | | | (744) | | |
Total property and equipment, net
|
| | | | | | $ | 1,759 | | | | | $ | 1,718 | | |
|
Cash consideration
|
| | | $ | 175 | | |
|
Estimate of future commission liability of $543, net of discount of $26
|
| | | | 517 | | |
|
Total value of customer list acquired
|
| | | $ | 692 | | |
Finite-lived intangible assets
|
| |
Estimated
useful life |
| |
2020
|
| |
2019
|
| | | | | | | ||||||||||||||||||||||||||||||||||||||||||
|
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net
|
| |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net
|
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||
Customer list
|
| |
5 years
|
| | | $ | 942 | | | | | $ | (414) | | | | | $ | 528 | | | | | $ | 942 | | | | | $ | (224) | | | | | $ | 718 | | | | | | | | | ||||||||||||
Trademarks
|
| |
10 years
|
| | | | 6 | | | | | | (1) | | | | | | 5 | | | | | | 6 | | | | | | (1) | | | | | | 5 | | | | | | | | | ||||||||||||
Total
|
| | | | | | $ | 948 | | | | | $ | (415) | | | | | $ | 533 | | | | | $ | 948 | | | | | $ | (225) | | | | | $ | 723 | | | | | | | | |
| | | | | |
As of
|
| |||||||||
| | |
Balance Sheet
Location |
| |
September 30,
2020 |
| |
September 30,
2019 |
| ||||||
Operating leases: | | | | | | | | | | | | | | | | |
Right-of-use asset
|
| | Operating Right-of-use asset | | | | $ | 737 | | | | | $ | 397 | | |
Operating lease liability, current
|
| | Operating lease liability, current | | | | | 430 | | | | | | 195 | | |
Operating lease liability, long term
|
| | Operating lease Liability, long term | | | | | 291 | | | | | | 175 | | |
| | |
Year Ended
September 30, 2020 |
| |
Year Ended
September 30, 2019 |
| ||||||
Lease cost | | | | | | | | | | | | | |
Short-term lease cost
|
| | | $ | 60 | | | | | $ | 340 | | |
Operating lease cost
|
| | | | 421 | | | | | | 109 | | |
Total
|
| | | $ | 481 | | | | | $ | 449 | | |
| | |
As of September 30,
2020 |
| |||
Other information | | | | | | | |
Weighted-average discount rate – operating lease
|
| | | | 5.00% | | |
Weighted-average remaining lease term – operating lease (in months)
|
| | | | 21 | | |
For Years September 30,
|
| | | | | | |
2021
|
| | | $ | 455 | | |
2022
|
| | | | 264 | | |
2023
|
| | | | 36 | | |
Total future minimum lease payments, undiscounted
|
| | | | 755 | | |
Less: Imputed interest for leases in excess of one year
|
| | | | 34 | | |
Present value of future minimum lease payments
|
| | | $ | 721 | | |
Present value of future minimum lease payments – current
|
| | | $ | 430 | | |
Present value of future minimum lease payments, non-current
|
| | | $ | 291 | | |
| | |
Year Ended September 30,
|
| |||
| | |
2020
|
| |
2019
|
|
Stock price
|
| |
$0.13
|
| |
$0.44 – $0.48
|
|
Exercise price
|
| |
$0.13
|
| |
$0.44 – $0.48
|
|
Dividend yield
|
| |
0%
|
| |
0%
|
|
Expected volatility
|
| |
60%
|
| |
60%
|
|
Risk-Free interest rate
|
| |
0.14% – 0.44%
|
| |
1.88% – 2.99%
|
|
Expected life (in years)
|
| |
2.4 – 6.08
|
| |
5.48 – 6.08
|
|
| | |
Options
|
| |
Weighted
Average Grant Date Fair Value |
| |
Weighted
Average Fair Value |
| |
Weighted
Average Remaining Life (years) |
| ||||||||||||
Outstanding – October 1, 2018
|
| | | | 7,197,652 | | | | | $ | 0.25 | | | | | $ | 0.10 | | | | | | 7.0 | | |
Granted
|
| | | | 5,076,337 | | | | | | 0.45 | | | | | | 0.26 | | | | | | | | |
Exercised
|
| | | | (306,925) | | | | | | 0.38 | | | | | | 0.21 | | | | | | | | |
Forfeited
|
| | | | (187,856) | | | | | | 0.41 | | | | | | 0.24 | | | | | | | | |
Outstanding – September 30, 2019
|
| | | | 11,779,208 | | | | | $ | 0.33 | | | | | $ | 0.17 | | | | | | 7.3 | | |
Granted
|
| | | | 2,200,532 | | | | | | 0.13 | | | | | | 0.07 | | | | | | | | |
Exercised
|
| | | | (89,966) | | | | | | 0.48 | | | | | | 0.27 | | | | | | | | |
Forfeited
|
| | | | (346,376) | | | | | | 0.48 | | | | | | 0.27 | | | | | | | | |
Outstanding – September 30, 2020
|
| | | | 13,543,398 | | | | | | 0.14 | | | | | | 0.15 | | | | | | 6.8 | | |
Exercisable as of September 30, 2020
|
| | | | 10,040,803 | | | | | $ | 0.15 | | | | | $ | 0.13 | | | | | | 5.5 | | |
| | |
Year Ended September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Software development expenses
|
| | | $ | 29 | | | | | $ | 35 | | |
Sales and marketing expenses
|
| | | | — | | | | | | 12 | | |
General and administrative expenses
|
| | | | 461 | | | | | | 270 | | |
Total stock-based compensation expense
|
| | | $ | 490 | | | | | $ | 317 | | |
| | |
Year Ended September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Current | | | | | | | | | | | | | |
Federal
|
| | | $ | — | | | | | $ | — | | |
State
|
| | | | — | | | | | | — | | |
Total current
|
| | | | — | | | | | | — | | |
Federal
|
| | | | 2,048 | | | | | | 2,196 | | |
State
|
| | | | 500 | | | | | | 969 | | |
Total deferred before valuation allowance
|
| | | | 2,548 | | | | | | 3,165 | | |
Change in valuation allowance
|
| | | | (2,548) | | | | | | (3,165) | | |
Total deferred expense, net of valuation allowance
|
| | | | — | | | | | | — | | |
Total income tax expense
|
| | | $ | — | | | | | $ | — | | |
| | |
Year Ended September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Tax at federal statutory rate
|
| | | | (21.0)% | | | | | | (21.0)% | | |
State and local tax
|
| | | | (5.4)% | | | | | | (9.3)% | | |
Non-deductible stock compensation
|
| | | | 0.3% | | | | | | 0.3% | | |
Non-deductible expenses
|
| | | | 0.7% | | | | | | 0.7% | | |
Change in deferred tax rate
|
| | | | 0.3% | | | | | | -% | | |
Change in valuation allowance
|
| | | | 25.1% | | | | | | 29.3% | | |
Effective tax rate
|
| | | | 0.0% | | | | | | 0.0% | | |
| | |
As of
September 30, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Deferred tax assets/(liability): | | | | | | | | | | | | | |
Net operating loss carryforwards
|
| | | $ | 9,769 | | | | | $ | 7,339 | | |
Stock-based compensation
|
| | | | 231 | | | | | | 199 | | |
Amortization of intangibles
|
| | | | 71 | | | | | | 45 | | |
Deferred tax assets
|
| | | | 10,071 | | | | | | 7,583 | | |
Valuation allowance
|
| | | | (10,042) | | | | | | (7,493) | | |
Deferred tax assets, net of valuation allowance
|
| | | | 29 | | | | | | 90 | | |
Deferred tax liabilities: | | | | | | | | | | | | | |
Property and equipment
|
| | | | (29) | | | | | | (90) | | |
Tax deferred tax liabilities
|
| | | | (29) | | | | | | (90) | | |
Deferred tax liabilities, net of valuation allowance and deferred tax
assets |
| | | $ | — | | | | | $ | — | | |
| | |
For the Three Months
Ended March 31, |
| |
For the Six Months
Ended March 31, |
| ||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2021
|
| |
2020
|
| ||||||||||||
Revenue | | | | $ | 9,273 | | | | | $ | 6,454 | | | | | $ | 17,259 | | | | | $ | 11,677 | | |
Operating expenses
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenue
|
| | | | 7,673 | | | | | | 5,831 | | | | | | 13,995 | | | | | | 11,588 | | |
Software development
|
| | | | 156 | | | | | | 241 | | | | | | 342 | | | | | | 471 | | |
General and administrative
|
| | | | 4,803 | | | | | | 2,807 | | | | | | 8,214 | | | | | | 5,815 | | |
Selling and marketing
|
| | | | 866 | | | | | | 923 | | | | | | 1,301 | | | | | | 1,955 | | |
Total operating expenses
|
| | | | 13,498 | | | | | | 9,802 | | | | | | 23,852 | | | | | | 19,829 | | |
Loss from operations
|
| | | | (4,225) | | | | | | (3,348) | | | | | | (6,593) | | | | | | (8,152) | | |
Other non-operating income (expense) | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest income (expense), net
|
| | | | 4 | | | | | | (61) | | | | | | 11 | | | | | | 30 | | |
Total other non-operating income (expense)
|
| | | | 4 | | | | | | (61) | | | | | | 11 | | | | | | 30 | | |
Net loss
|
| | | $ | (4,221) | | | | | $ | (3,409) | | | | | $ | (6,582) | | | | | $ | (8,122) | | |
Weighted average shares outstanding, basic and diluted
|
| | | | 12,747,462 | | | | | | 12,513,301 | | | | | | 12,681,029 | | | | | | 12,510,955 | | |
Net loss per share, basic and diluted
|
| | | $ | (0.33) | | | | | $ | (0.27) | | | | | $ | (0.52) | | | | | $ | (0.65) | | |
| | |
As of
|
| |||||||||
| | |
March 31, 2021
|
| |
September 30, 2020
|
| ||||||
| | |
(unaudited)
|
| | | | | | | |||
Assets | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 7,511 | | | | | $ | 12,162 | | |
Restricted cash
|
| | | | 415 | | | | | | 114 | | |
Accounts receivable
|
| | | | 1,072 | | | | | | 1,092 | | |
Prepaid expenses and other current assets
|
| | | | 2,114 | | | | | | 1,011 | | |
Total current assets
|
| | | | 11,112 | | | | | | 14,379 | | |
Non-current assets | | | | | | | | | | | | | |
Investment in joint venture
|
| | | | 200 | | | | | | 200 | | |
Other non-current assets
|
| | | | 136 | | | | | | 107 | | |
Intangible assets, net
|
| | | | 942 | | | | | | 533 | | |
Operating right-of-use asset
|
| | | | 569 | | | | | | 737 | | |
Deferred recapitalization costs
|
| | | | 3,173 | | | | | | — | | |
Property and equipment, net
|
| | | | 1,674 | | | | | | 1,759 | | |
Total assets
|
| | | $ | 17,806 | | | | | $ | 17,715 | | |
Liabilities and Stockholders’ Equity | | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | | |
Accounts payable and accrued expenses
|
| | | $ | 4,011 | | | | | $ | 776 | | |
Deferred revenue
|
| | | | 4,415 | | | | | | 3,973 | | |
Operating lease liability, current
|
| | | | 394 | | | | | | 430 | | |
Note payable
|
| | | | 1,165 | | | | | | 1,165 | | |
Total current liabilities
|
| | | | 9,985 | | | | | | 6,344 | | |
Non-current liabilities | | | | | | | | | | | | | |
Operating lease liability, long-term
|
| | | | 125 | | | | | | 291 | | |
Total liabilities
|
| | | | 10,110 | | | | | | 6,635 | | |
Commitments and Contingencies (Note 9) | | | | | | | | | | | | | |
Stockholders’ Equity | | | | | | | | | | | | | |
Preferred stock – Series Seed, $0.00001 par value, 2,817,000 shares authorized, issued and outstanding at March 31, 2021 and September 30, 2020, respectively.
|
| | | | — | | | | | | — | | |
Preferred stock – Series A, $0.00001 par value, 6,734,526 shares
authorized, 6,734,517 issued and outstanding at March 31, 2021 and September 30, 2020, respectively. |
| | | | — | | | | | | — | | |
Preferred stock – Series B, $0.00001 par value, 12,660,000 shares authorized at March 31, 2021 and September 30, 2020, respectively. 12,565,294 shares issued and outstanding at March 31, 2021 and September 30, 2020, respectively.
|
| | | | — | | | | | | — | | |
Common stock, $0.00001 par value; 50,300,000 authorized; 13,756,294 and 12,592,851 shares issued and outstanding at March 31, 2021 and September 30, 2020, respectively.
|
| | | | — | | | | | | — | | |
Additional paid in capital
|
| | | | 51,416 | | | | | | 48,218 | | |
Accumulated deficit
|
| | | | (43,720) | | | | | | (37,138) | | |
Total stockholders’ equity
|
| | | | 7,696 | | | | | | 11,080 | | |
Total Liabilities and Stockholders’ Equity
|
| | | $ | 17,806 | | | | | $ | 17,715 | | |
| | |
Preferred Stock –
Series Seed |
| |
Preferred Stock –
Series A |
| |
Preferred Stock –
Series B |
| |
Common Stock
|
| |
Additional
Paid- In Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Equity |
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2021
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 13,693,274 | | | | | $ | — | | | | | $ | 49,495 | | | | | $ | (39,499) | | | | | $ | 9,996 | | |
Stock option exercise
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 63,020 | | | | | | — | | | | | | 17 | | | | | | — | | | | | | 17 | | |
Stock-based compensation –
stock options |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 109 | | | | | | — | | | | | | 109 | | |
Stock-based compensation –
restricted stock |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,795 | | | | | | — | | | | | | 1,795 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,221) | | | | | | (4,221) | | |
Balance at March 31, 2021
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 13,756,294 | | | | | $ | — | | | | | $ | 51,416 | | | | | $ | (43,720) | | | | | $ | 7,696 | | |
Balance at January 1, 2020
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 12,513,301 | | | | | $ | — | | | | | $ | 47,809 | | | | | $ | (31,691) | | | | | $ | 16,118 | | |
Stock-based compensation –
stock options |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 87 | | | | | | — | | | | | | 87 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (3,409) | | | | | | (3,409) | | |
Balance at March 31, 2020
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 12,513,301 | | | | | $ | — | | | | | $ | 47,896 | | | | | $ | (35,100) | | | | | $ | 12,796 | | |
Balance at October 1, 2020
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 12,592,851 | | | | | $ | — | | | | | $ | 48,218 | | | | | $ | (37,138) | | | | | $ | 11,080 | | |
Issuance of restricted stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,085,840 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Stock option exercise
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 77,603 | | | | | | — | | | | | | 19 | | | | | | — | | | | | | 19 | | |
Stock-based compensation –
restricted stock |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,822 | | | | | | — | | | | | | 2,822 | | |
Stock-based compensation –
stock options |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 357 | | | | | | — | | | | | | 357 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (6,582) | | | | | | (6,582) | | |
Balance at March 31, 2021
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 13,756,294 | | | | | $ | — | | | | | $ | 51,416 | | | | | $ | (43,720) | | | | | $ | 7,696 | | |
Balance at October 1, 2019
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 12,502,885 | | | | | $ | — | | | | | $ | 47,713 | | | | | $ | (26,978) | | | | | $ | 20,735 | | |
Stock option exercise
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,416 | | | | | | — | | | | | | 5 | | | | | | — | | | | | | 5 | | |
Stock-based compensation –
stock options |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 178 | | | | | | — | | | | | | 178 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (8,122) | | | | | | (8,122) | | |
Balance at March 31, 2020
|
| | | | 2,817,000 | | | | | $ | — | | | | | | 6,734,517 | | | | | $ | — | | | | | | 12,565,294 | | | | | $ | — | | | | | | 12,513,301 | | | | | $ | — | | | | | $ | 47,896 | | | | | $ | (35,100) | | | | | $ | 12,796 | | |
| | |
For the Six Months
Ended March 31, |
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Cash Flows From Operating Activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (6,582) | | | | | $ | (8,122) | | |
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities:
|
| | | | | | | | | | | | |
Depreciation and amortization
|
| | | | 265 | | | | | | 265 | | |
Stock-based compensation
|
| | | | 3,179 | | | | | | 178 | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Prepaid expenses and other current assets
|
| | | | (1,203) | | | | | | (429) | | |
Accounts receivable
|
| | | | 20 | | | | | | (178) | | |
Other non-current assets
|
| | | | 71 | | | | | | 90 | | |
Operating lease assets/liabilities
|
| | | | (34) | | | | | | (21) | | |
Accounts payable and accrued expenses
|
| | | | 3,235 | | | | | | (1,502) | | |
Deferred revenue
|
| | | | 442 | | | | | | 375 | | |
Net cash used in operating activities
|
| | | | (607) | | | | | | (9,344) | | |
Cash Flows From Investing Activities: | | | | | | | | | | | | | |
Purchase of domain name
|
| | | | (503) | | | | | | — | | |
Purchase of property and equipment
|
| | | | (86) | | | | | | (368) | | |
Net cash used in investing activities
|
| | | | (589) | | | | | | (368) | | |
Cash Flows From Financing Activities: | | | | | | | | | | | | | |
Proceeds from the exercise of common stock options
|
| | | | 19 | | | | | | 5 | | |
Deferred recapitalization costs related to the merger
|
| | | | (3,173) | | | | | | — | | |
Net cash (used in) provided by financing activities
|
| | | | (3,154) | | | | | | 5 | | |
Net decrease in cash and cash equivalents and restricted cash
|
| | | | (4,350) | | | | | | (9,707) | | |
Cash and cash equivalents and restricted cash – beginning
|
| | | | 12,276 | | | | | | 22,291 | | |
Cash and cash equivalents and restricted cash – ending
|
| | | $ | 7,926 | | | | | $ | 12,584 | | |
Cash and cash equivalents
|
| | | $ | 7,511 | | | | | $ | 12,467 | | |
Restricted cash
|
| | | | 415 | | | | | | 117 | | |
Total | | | | $ | 7,926 | | | | | $ | 12,584 | | |
Supplemental cash flow information | | | | | | | | | | | | | |
Cash paid for:
|
| | | | | | | | | | | | |
Interest
|
| | | $ | — | | | | | $ | — | | |
Income Taxes
|
| | | $ | — | | | | | $ | — | | |
Non-cash investing and financing activities | | | | | | | | | | | | | |
Adoption of new leases under ASC 842 entered into during the period
|
| | | $ | 12 | | | | | $ | 767 | | |
| | |
For the Three Months Ended
March 31, |
| |||||||||
Product Line
|
| |
2021
|
| |
2020
|
| ||||||
Short distance
|
| | | $ | 1,049 | | | | | $ | 1,787 | | |
MediMobility organ transport and jet
|
| | | | 7,729 | | | | | | 4,588 | | |
Other
|
| | | | 495 | | | | | | 79 | | |
Total Revenue
|
| | | $ | 9,273 | | | | | $ | 6,454 | | |
| | |
For the Six Months Ended
March 31, |
| |||||||||
Product Line
|
| |
2021
|
| |
2020
|
| ||||||
Short distance
|
| | | $ | 3,179 | | | | | $ | 5,138 | | |
MediMobility organ transport and jet
|
| | | | 13,253 | | | | | | 6,453 | | |
Other
|
| | | | 827 | | | | | | 86 | | |
Total Revenue
|
| | | $ | 17,259 | | | | | $ | 11,677 | | |
| | | | | |
March 31, 2021
|
| |
September 30, 2020
|
| | ||||||||||||||||||||||||||||||||
| | | | | |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net
|
| |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Net
|
| | ||||||||||||||||||||
Intangible assets
|
| |
Estimated useful life
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
Customer list
|
| |
5 years
|
| | | $ | 942 | | | | | $ | (507) | | | | | $ | 435 | | | | | $ | 942 | | | | | $ | (414) | | | | | $ | 528 | | | | ||
Domain name
|
| |
Indefinite
|
| | | | 503 | | | | | | — | | | | | | 503 | | | | | | — | | | | | | — | | | | | | — | | | | ||
Trademarks
|
| |
10 years
|
| | | | 6 | | | | | | (2) | | | | | | 4 | | | | | | 6 | | | | | | (1) | | | | | | 5 | | | | ||
Total
|
| | | | | | $ | 1,451 | | | | | $ | (509) | | | | | $ | 942 | | | | | $ | 948 | | | | | $ | (415) | | | | | $ | 533 | | | | | |
| | |
As of
|
| |||||||||
Operating leases:
|
| |
March
31, 2021 |
| |
September 30,
2020 |
| ||||||
Operating right-of-use asset
|
| | | $ | 569 | | | | | $ | 737 | | |
Operating lease liability, current
|
| | | | 394 | | | | | | 430 | | |
Operating lease liability, long term
|
| | | | 125 | | | | | | 291 | | |
Lease cost
|
| |
For the Three Months Ended March 31,
|
| |
For the Six Months Ended March 31,
|
| ||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2021
|
| |
2020
|
| ||||||||||||
Short-term lease cost
|
| | | $ | 12 | | | | | $ | 8 | | | | | $ | 52 | | | | | $ | 30 | | |
Operating lease cost
|
| | | | 115 | | | | | | 138 | | | | | | 227 | | | | | | 182 | | |
Total
|
| | | $ | 127 | | | | | $ | 146 | | | | | $ | 279 | | | | | $ | 212 | | |
| | |
As of March 31,
2021 |
| |
As of September 30,
2020 |
| ||||||
Weighted-average discount rate – operating lease
|
| | | | 5.00% | | | | | | 5.00% | | |
Weighted-average remaining lease term – operating lease (in months)
|
| | | | 16 | | | | | | 21 | | |
For the Years Ended September 30,
|
| | | | | | |
2021 (six months)
|
| | | $ | 233 | | |
2022
|
| | | | 270 | | |
2023
|
| | | | 36 | | |
Total future minimum lease payments, undiscounted
|
| | | | 539 | | |
Less: Imputed interest for leases in excess of one year
|
| | | | 20 | | |
Present value of future minimum lease payments
|
| | | $ | 519 | | |
Present value of future minimum lease payments – current
|
| | | $ | 394 | | |
Present value of future minimum lease payments – non-current
|
| | | $ | 125 | | |
|
Stock price
|
| | | $ | 7.28 | | |
|
Exercise price
|
| | | $ | 7.28 | | |
|
Dividend yield
|
| | | | 0% | | |
|
Expected volatility
|
| | | | 60% | | |
|
Risk-Free interest rate
|
| | | | 0.63% | | |
|
Expected life (in years)
|
| | | | 6.08 | | |
| | |
Options
|
| |
Weighted
Average Exercise Price |
| |
Weighted
Average Grant Date Fair Value |
| |
Weighted
Average Remaining Life (years) |
| ||||||||||||
Outstanding – October 1, 2020
|
| | | | 13,543,398 | | | | | $ | 0.14 | | | | | $ | 0.15 | | | | | | 6.8 | | |
Granted
|
| | | | 15,000 | | | | | | 7.28 | | | | | | 4.00 | | | | | | | | |
Exercised
|
| | | | (77,603) | | | | | | 0.24 | | | | | | 0.18 | | | | | | | | |
Forfeited
|
| | | | (157,480) | | | | | | 0.18 | | | | | | 0.09 | | | | | | | | |
Outstanding – March 31, 2021
|
| | | | 13,323,315 | | | | | $ | 0.14 | | | | | $ | 0.15 | | | | | | 6.3 | | |
Exercisable as of March 31, 2021
|
| | | | 9,595,015 | | | | | $ | 0.14 | | | | | $ | 0.14 | | | | | | 5.5 | | |
| | |
Shares of Restricted
Stock |
| |
Weighted
Average Grant Date Fair Value |
| ||||||
Non-vested – October 1, 2020
|
| | | | — | | | | | $ | — | | |
Granted
|
| | | | 1,085,840 | | | | | | 7.28 | | |
Vested
|
| | | | (100,000) | | | | | | 7.28 | | |
Non-vested – March 31, 2021
|
| | | | 985,840 | | | | | $ | 7.28 | | |
| | |
For the Three Months Ended March 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Software development
|
| | | $ | 71 | | | | | $ | 6 | | |
General and administrative
|
| | | | 1,833 | | | | | | 75 | | |
Selling and marketing
|
| | | | — | | | | | | 6 | | |
Total stock-based compensation expense
|
| | | $ | 1,904 | | | | | $ | 87 | | |
| | |
For the Six Months Ended March 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Software development
|
| | | $ | 88 | | | | | $ | 12 | | |
General and administrative
|
| | | | 3,091 | | | | | | 154 | | |
Selling and marketing
|
| | | | — | | | | | | 12 | | |
Total stock-based compensation expense
|
| | | $ | 3,179 | | | | | $ | 178 | | |